Nothing Special   »   [go: up one dir, main page]

KR101593465B1 - Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same - Google Patents

Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same Download PDF

Info

Publication number
KR101593465B1
KR101593465B1 KR1020130075402A KR20130075402A KR101593465B1 KR 101593465 B1 KR101593465 B1 KR 101593465B1 KR 1020130075402 A KR1020130075402 A KR 1020130075402A KR 20130075402 A KR20130075402 A KR 20130075402A KR 101593465 B1 KR101593465 B1 KR 101593465B1
Authority
KR
South Korea
Prior art keywords
group
substituted
unsubstituted
compound
mol
Prior art date
Application number
KR1020130075402A
Other languages
Korean (ko)
Other versions
KR20150002072A (en
Inventor
현서용
윤용호
김대환
오현진
Original Assignee
(주)피엔에이치테크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)피엔에이치테크 filed Critical (주)피엔에이치테크
Priority to KR1020130075402A priority Critical patent/KR101593465B1/en
Publication of KR20150002072A publication Critical patent/KR20150002072A/en
Application granted granted Critical
Publication of KR101593465B1 publication Critical patent/KR101593465B1/en

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • H10K85/636Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine comprising heteroaromatic hydrocarbons as substituents on the nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H10K50/12OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers comprising dopants
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/631Amine compounds having at least two aryl rest on at least one amine-nitrogen atom, e.g. triphenylamine
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

하기 구조식 1로 표시되는 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자가 개시된다. 이에 의하여, 전기적 안정성 및 전자와 정공 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상시킬 수 있는 호스트, 정공수송 물질 및 전자수송 물질로 사용할 수 있는 유기전계발광소자용 화합물 및 유기전계발광소자를 제공할 수 있다.
[구조식 1]

Figure 112013058279111-pat00114
An organic electroluminescent device compound represented by the following structural formula 1 and an organic electroluminescent device comprising the same are disclosed. As a result, it can be used as a host, a hole transporting material, and an organic light emitting device which can be used as an electron transporting material, which can improve the luminous efficiency of a phosphorescent light emitting material because of its excellent electrical stability, electron and hole transporting ability, A compound and an organic electroluminescent device can be provided.
[Structural formula 1]
Figure 112013058279111-pat00114

Description

새로운 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자{NOVEL COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME}TECHNICAL FIELD [0001] The present invention relates to a compound for a novel organic electroluminescent device and an organic electroluminescent device including the same. BACKGROUND OF THE INVENTION [0002]

본 발명은 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자에 관한 것으로, 보다 상세하게는 유기전계발광소자의 발광효율을 향상시킬 수 있는 유기전계발광소자용 화합물 및 그를 포함하는 유기전계발광소자에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a compound for an organic electroluminescent device and an organic electroluminescent device including the same, and more particularly to a compound for an organic electroluminescent device capable of improving the luminous efficiency of the organic electroluminescent device, Device.

정보화 사회로의 움직임이 가속화되면서 평판 디스플레이의 비중이 점차 증가하고 있다. 그 중 LCD(liquid crystal display)가 현재 가장 많이 쓰이고 있지만 액정에 전압을 가해 백라이트로부터의 빛을 컬러필터로 통과시켜 삼원색을 얻음으로써 화면을 만드는 방식이며, 유기EL(OLED; Organic Light Emitting Diodes)은 자체발광 소자로써 시야각 및 대조비 등이 우수하고, 경량 및 박형이 가능하며 휘는 성질의 기판에도 사용할 수 있어, 투명, 플렉서블 디스플레이가 가능하여 차세대 표시소자로서 주목을 받고 있다.As the move to the information society accelerates, the proportion of flat panel displays is gradually increasing. LCD (liquid crystal display) is the most widely used method, but it is a method to make a screen by applying voltage to liquid crystal and passing light from backlight through color filter to obtain three primary colors. Organic light emitting diodes (OLED) As a self-luminous element, it has excellent viewing angle and contrast ratio, is lightweight and thin, can be used for a substrate having a bending property, and is capable of transparent and flexible display, and has attracted attention as a next generation display element.

유기EL은 유기물 박막에 음극과 양극을 통하여 주입된 전자와 정공이 재결합을 통해 여기자를 형성하고, 형성된 그 여기자로부터 특정한 파장의 빛이 발생하는 현상으로 1963년 Pope 등에 의해 안트라센(anthracene)의 단결정으로부터 처음으로 발견되었고 이후 이스트만 코닥사의 탕(C.W Tang)등에 의해 적층형의 유기EL 소자의 보고(C.W Tang, S.A Vanslyke, Applied physics Letters. 51권 913p, 1987) 된 이후 활발히 연구되고 있다.Organic EL is a phenomenon in which excitons are formed by recombination of electrons and holes injected through a cathode and an anode into an organic thin film, and light of a specific wavelength is generated from the excitons formed. In 1963, Pope et al. Reported that an anthracene single crystal (CW Tang, SA Vanslyke, Applied Physics Letters, Vol. 51, No. 913p, 1987) by Eastman Kodak Co., Ltd. (CW Tang) et al.

유기전계발광소자에 사용되는 유기물질은 크게 고분자와 저분자 형태로 나누어지며 저분자는 순 유기물질과 메탈과 킬레이트를 형성한 메탈 콤플렉스로 나눌 수 있다.Organic materials used in organic electroluminescent devices are classified into polymer and small molecule, and small molecules can be divided into pure organic material and metal complex which forms metal and chelate.

고분자 물질은 다양한 기능의 유닛을 고분자 체인에 결합하여 다 기능의 물질을 만들어 낼 수 있으나, 합성물 정제시나 소자 형성 시 어려움이 있고, 저분자 물질은 각 특성의 물질을 합성할 수 있으나 다기능의 특성을 나타내는 물질 합성에는 한계가 있다 하겠다. Polymers can combine various functional units into polymer chains to produce multifunctional materials. However, it is difficult to purify compounds or to form devices, and low-molecular materials can synthesize materials of various properties, but they exhibit multifunctional properties There is a limit to the synthesis of materials.

유기전계발광소자를 적층구조로 형성할 수 있다. 적층구조의 장점으로는 각 기능에 맞게끔 물질을 선택하여 사용할 수 있는 것인데, 일반적으로 소자구조는 양극과 음극 사이에 정공주입층, 정공수송층, 발광층, 전자수송층, 전자주입층을 형성하여 발광층에서 여기자 형성을 쉽게 하게 하고, 발광 효율을 높일 수 있다.The organic electroluminescent device can be formed in a laminated structure. In general, the device structure is formed by forming a hole injecting layer, a hole transporting layer, a light emitting layer, an electron transporting layer, and an electron injecting layer between an anode and a cathode to form a light emitting layer The exciton formation can be facilitated and the emission efficiency can be enhanced.

발광물질은 호스트물질과 발광물질(도펀트)물질로 크게 나눌 수 있고, 발광물질은 발광 기작에 따라 형광과 인광으로 구별된다. The luminescent material can be roughly divided into a host material and a luminescent material (dopant) material, and the luminescent material is distinguished by fluorescence and phosphorescence depending on the luminescence mechanism.

화합물 내 전자의 여기 상태는 일중항 대 삼중항의 비율이 1:3으로 삼중항 상태가 3배 정도 더 생성된다. 따라서, 일중항 상태에서 기저상태로 떨어지는 형광의 내부양자효율이 25%에 그치는 반면 삼중항 상태에서 기저상태로 떨어지는 인광의 내부양자효율은 75%이다. 또한 일중항 상태에서 삼중항 상태로 계간전이가 일어날 경우 내부양자효율의 이론적 한계치는 100%에 달한다. 이러한 점을 이용해 발광효율을 개선한 발광재료가 인광 발광재료이다.The excited state of the electrons in the compound is 1: 3 ratio of singlet to triplet, and triplet state is generated about 3 times more. Thus, the internal quantum efficiency of phosphorescence falling from the triplet state to the base state is 75% while the internal quantum efficiency of the fluorescence falling from the singlet state to the ground state is only 25%. In addition, the theoretical limit of internal quantum efficiency reaches 100% when the interplanar transition from singlet state to triplet state occurs. A light emitting material that improves the light emitting efficiency by using this point is a phosphorescent material.

유기물의 특성상 인광 발광은 어려움이 있어, 인광 발광재료로는 전이금속(이리듐)을 이용환 유기금속화합물이 개발되고 있으며, 이를 보조하는 호스트 물질로 유기물질이 이용되고 있다. 인광발광물질을 보조하는 물질(호스트)는 밴드갭이 넓고 삼중항 상태 에너지가 높아야 한다. 전류효율과 발광효율이 우수한 인광물질이 각광을 받고 있으나 전자 수송능력과 홀 수송능력, 열적, 전기적으로 안정한 호스트 물질과 정공이 여기자를 형성할 때까지 유지되고, 전자 수송능력이 뛰어난 유기전계발광소자용 화합물의 개발이 필요한 실정이다.Due to the nature of organic materials, it is difficult to emit phosphorescence. As a phosphorescent material, transition metal (iridium) is utilized as an organometallic compound, and an organic material is used as a host material to assist it. The material that assists the phosphorescent material (host) should have a wide bandgap and a high triplet state energy. A phosphorescent material having excellent current efficiency and luminous efficiency is received in the spotlight, but the electron transporting ability, the hole transporting ability, the host material which is thermally and electrically stable, and the organic electroluminescent device It is necessary to develop a compound for use.

본 발명은 전기적 안정성 및 전자와 정공 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상시킬 수 있는 호스트로서 발광층에 사용될 수 있는 유기발광소자용 화합물 및 이를 포함하는 유기전계발광소자를 제공할 수 있다.The present invention relates to a compound capable of being used for a light emitting layer as a host which is excellent in electrical stability, electron and hole transporting ability, and has high triplet state energy and can improve the luminous efficiency of a phosphorescent light emitting material, A light emitting element can be provided.

또한 본 발명은 유기전계발광소자의 전자수송재료나, 정공수송재료에 사용될 수 있는 유기발광소자용 화합물 및 이를 포함하는 유기전기 발광소자를 제공할 수 있다.In addition, the present invention can provide an organic electroluminescent compound that can be used for an electron transporting material and a hole transporting material of an organic electroluminescent device, and an organic electroluminescent device including the same.

그러나, 본원이 해결하고자 하는 과제는 이상에서 언급한 과제로 제한되지 않으며, 언급되지 않은 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the problems to be solved by the present invention are not limited to the above-mentioned problems, and other problems not mentioned can be clearly understood by those skilled in the art from the following description.

본 발명의 일 측면에 따르면, 하기 구조식 1로 표시되는 유기전계발광소자용 화합물이 제공될 수 있다. According to an aspect of the present invention, a compound for an organic electroluminescence device represented by the following structural formula 1 may be provided.

[구조식 1][Structural formula 1]

Figure 112013058279111-pat00001
Figure 112013058279111-pat00001

상기 구조식 1에서,In the above formula 1,

A는 수소원자, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,A is a hydrogen atom, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl Lt; / RTI &

B는 원자가결합, 치환 또는 비치환된 C1 내지 C30의 알킬렌기, 치환 또는 비치환된 C3 내지 C30 시클로알킬렌기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬렌기, 치환 또는 비치환된 C6 내지 C30 아릴렌기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴렌기이고,B is a substituted or unsubstituted C1 to C30 alkylene group, a substituted or unsubstituted C3 to C30 cycloalkylene group, a substituted or unsubstituted C1 to C30 heterocycloalkylene group, a substituted or unsubstituted C6 to C30 An arylene group, or a substituted or unsubstituted C1 to C30 heteroarylene group,

X1 내지 X8은 서로 같거나 다를 수 있고, X1 내지 X8은 각각 독립적으로 질소원자 또는

Figure 112013058279111-pat00002
이고,X 1 to X 8 may be the same or different from each other, X 1 to X 8 each independently represents a nitrogen atom or
Figure 112013058279111-pat00002
ego,

R5는 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,R 5 represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, Or a substituted or unsubstituted C1 to C30 heteroaryl group,

R1 내지 R4는 서로 같거나 다를 수 있고, R1 내지 R4는 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이다.R 1 to R 4 may be the same or different from one another and each of R 1 to R 4 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, A substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group.

본 발명의 일 실시예에 따르면, 바람직하게는,According to an embodiment of the present invention, preferably,

A는 수소원자,

Figure 112013058279111-pat00003
,
Figure 112013058279111-pat00004
또는
Figure 112013058279111-pat00005
이고, A represents a hydrogen atom,
Figure 112013058279111-pat00003
,
Figure 112013058279111-pat00004
or
Figure 112013058279111-pat00005
ego,

X9 내지 X15, X17, X19 및 X20은 서로 같거나 다를 수 있고, X9 내지 X15, X17, X19 및 X20은 각각 독립적으로 질소원자 또는

Figure 112013058279111-pat00006
이고, X 9 to X 15 , X 17 , X 19 and X 20 may be the same or different from each other, and each of X 9 to X 15 , X 17 , X 19 and X 20 is independently a nitrogen atom or
Figure 112013058279111-pat00006
ego,

R6은 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 R6은 R6이 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로아릴기를 형성할 수 있고,R 6 represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted or C1 to C30 heteroaryl ring, or R 6 is R 6 is the combination with the adjacent carbon atoms and more carbon atoms substituted or unsubstituted fused bonding a C3 to C30 cycloalkyl group, a substituted or unsubstituted A substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group,

X16 및 X18은 서로 같거나 다를 수 있고, X16 및 X18은 각각 독립적으로

Figure 112013058279111-pat00007
, 또는
Figure 112013058279111-pat00008
이고,X 16 And X 18 may be the same or different from each other, and X 16 And X < 18 > are each independently
Figure 112013058279111-pat00007
, or
Figure 112013058279111-pat00008
ego,

R7 내지 R9는 서로 같거나 다를 수 있고, R7 내지 R9는 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 R7 내지 R9 중 적어도 어느 하나는 그 어느 하나가 결합된 탄소원자 또는 질소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로아릴기를 형성할 수 있다.R 7 to R 9 may be the same or different from each other, and each of R 7 to R 9 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, A substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group, or R < 7 > to R < 9 > At least one of them is a fused C3 to C30 cycloalkyl group, a substituted or unsubstituted fused C1 to C30 hetero ring, a substituted or unsubstituted fused C3 to C30 cycloalkyl group, A substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group.

본 발명의 다른 실시예에 따르면, 바람직하게는,According to another embodiment of the present invention, preferably,

A는 수소원자,

Figure 112013058279111-pat00009
,
Figure 112013058279111-pat00010
,
Figure 112013058279111-pat00011
,
Figure 112013058279111-pat00012
,
Figure 112013058279111-pat00013
, 또는
Figure 112013058279111-pat00014
이고, A represents a hydrogen atom,
Figure 112013058279111-pat00009
,
Figure 112013058279111-pat00010
,
Figure 112013058279111-pat00011
,
Figure 112013058279111-pat00012
,
Figure 112013058279111-pat00013
, or
Figure 112013058279111-pat00014
ego,

X21 내지 X24는 서로 같거나 다를 수 있고, X21 내지 X24는 각각 독립적으로 질소원자 또는

Figure 112013058279111-pat00015
이고, X 21 to X 24 may be the same or different from each other, and each of X 21 to X 24 independently represents a nitrogen atom or
Figure 112013058279111-pat00015
ego,

R30은 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이거나, 또는 R30은 R30이 결합된 탄소원자의 이웃한 탄소원자와 추가로 결합하여 치환 또는 비치환된 융합된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 융합된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 융합된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 융합된 C1 내지 C30 헤테로아릴기를 형성할 수 있고,R 30 represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted or C1 to C30 heteroaryl ring, or R 30 is R 30 a in conjunction with the adjacent carbon atoms and more carbon atoms substituted or unsubstituted fused bonding a C3 to C30 cycloalkyl group, a substituted or unsubstituted A substituted or unsubstituted fused C1 to C30 heterocycloalkyl group, a substituted or unsubstituted fused C6 to C30 aryl group, or a substituted or unsubstituted fused C1 to C30 heteroaryl group,

Y1 및 Y2는 서로 같거나 다를 수 있고, Y1 및 Y2는 각각 독립적으로 산소원자, 황원자,

Figure 112013058279111-pat00016
, 또는
Figure 112013058279111-pat00017
이고,Y 1 And Y 2 may be the same or different from each other, and Y 1 And Y 2 each independently represent an oxygen atom, a sulfur atom,
Figure 112013058279111-pat00016
, or
Figure 112013058279111-pat00017
ego,

Ar2는 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 2 represents a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, An unsubstituted C1 to C30 heteroaryl group,

R31 및 R32는 서로 같거나 다를 수 있고, R31 및 R32는 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,R 31 and R 32 may be the same or different from each other, and R 31 and R 32 each independently represent a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, A substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group,

Ar1은 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 1 represents a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, An unsubstituted C1 to C30 heteroaryl group,

R10 내지 R29는 서로 같거나 다를 수 있고, R10 내지 R29는 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기일 수 있다.R 10 to R 29 may be the same or different from each other and each of R 10 to R 29 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Substituted C1 to C30 heterocycloalkyl groups, substituted or unsubstituted C6 to C30 aryl groups, or substituted or unsubstituted C1 to C30 heteroaryl groups.

본 발명의 다른 또 하나의 실시예에 따르면, 바람직하게는,According to another embodiment of the present invention, preferably,

B는 원자가결합,

Figure 112013058279111-pat00018
,
Figure 112013058279111-pat00019
,
Figure 112013058279111-pat00020
,
Figure 112013058279111-pat00021
,
Figure 112013058279111-pat00022
, 치환 또는 비치환된 C1 내지 C30의 알킬렌기, 치환 또는 비치환된 C3 내지 C30 시클로알킬렌기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬렌기이고,B is a valence bond,
Figure 112013058279111-pat00018
,
Figure 112013058279111-pat00019
,
Figure 112013058279111-pat00020
,
Figure 112013058279111-pat00021
,
Figure 112013058279111-pat00022
, A substituted or unsubstituted C1 to C30 alkylene group, a substituted or unsubstituted C3 to C30 cycloalkylene group, or a substituted or unsubstituted C1 to C30 heterocycloalkylene group,

X25는 질소원자 또는

Figure 112013058279111-pat00023
이고, X < 25 > is a nitrogen atom or
Figure 112013058279111-pat00023
ego,

Y3 및 Y4는 서로 같거나 다를 수 있고, Y3 및 Y4는 각각 독립적으로 산소원자, 황원자,

Figure 112013058279111-pat00024
, 또는
Figure 112013058279111-pat00025
이고,Y 3 And Y 4 may be the same or different from each other, and Y 3 And Y < 4 > each independently represent an oxygen atom, a sulfur atom,
Figure 112013058279111-pat00024
, or
Figure 112013058279111-pat00025
ego,

Ar3은 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 3 represents a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, a substituted or unsubstituted C1 to C30 heterocycloalkyl group, a substituted or unsubstituted C6 to C30 aryl group, An unsubstituted C1 to C30 heteroaryl group,

R48 내지 R50은 서로 같거나 다를 수 있고, R48 내지 R50은 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,R 48 to R 50 may be the same or different from each other, and each of R 48 to R 50 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, A substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group,

R33 내지 R47은 서로 같거나 다를 수 있고, R33 내지 R47은 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기일 수 있다.R 33 to R 47 may be the same or different from each other, and each of R 33 to R 47 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Substituted C1 to C30 heterocycloalkyl groups, substituted or unsubstituted C6 to C30 aryl groups, or substituted or unsubstituted C1 to C30 heteroaryl groups.

본 발명의 다른 또 하나의 실시예에 따르면, 바람직하게는,According to another embodiment of the present invention, preferably,

B는 원자가결합,

Figure 112013058279111-pat00026
,
Figure 112013058279111-pat00027
,
Figure 112013058279111-pat00028
,
Figure 112013058279111-pat00029
, 또는
Figure 112013058279111-pat00030
이고,B is a valence bond,
Figure 112013058279111-pat00026
,
Figure 112013058279111-pat00027
,
Figure 112013058279111-pat00028
,
Figure 112013058279111-pat00029
, or
Figure 112013058279111-pat00030
ego,

X25는 질소원자 또는

Figure 112013058279111-pat00031
이고, X < 25 > is a nitrogen atom or
Figure 112013058279111-pat00031
ego,

R48은 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기이고,R 48 is a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, or a substituted or unsubstituted C1 to C30 heterocycloalkyl group,

Y3 및 Y4는 서로 같거나 다를 수 있고, Y3 및 Y4는 각각 독립적으로 산소원자, 황원자,

Figure 112013058279111-pat00032
, 또는
Figure 112013058279111-pat00033
이고,Y 3 And Y 4 may be the same or different from each other, and Y 3 And Y < 4 > each independently represent an oxygen atom, a sulfur atom,
Figure 112013058279111-pat00032
, or
Figure 112013058279111-pat00033
ego,

Ar3은 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,Ar 3 is a substituted or unsubstituted C6 to C30 aryl group or a substituted or unsubstituted C1 to C30 heteroaryl group,

R49 및 R50은 서로 같거나 다를 수 있고, R49 및 R50은 각각 독립적으로 수소원자, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기이고,R 49 and R 50 may be the same or different from each other, and R 49 and R 50 are each independently a hydrogen atom, a substituted or unsubstituted C6 to C30 aryl group, or a substituted or unsubstituted C1 to C30 heteroaryl group,

R33 내지 R47은 서로 같거나 다를 수 있고, R33 내지 R47은 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기일 수 있다.R 33 to R 47 may be the same or different from each other, and each of R 33 to R 47 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Substituted C1 to C30 heterocycloalkyl groups, substituted or unsubstituted C6 to C30 aryl groups, or substituted or unsubstituted C1 to C30 heteroaryl groups.

본 발명의 다른 또 하나의 실시예에 따르면, 바람직하게는,According to another embodiment of the present invention, preferably,

R33 내지 R47은 서로 같거나 다를 수 있고, R33 내지 R47은 각각 독립적으로 수소원자,

Figure 112013058279111-pat00034
, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기이고,R 33 to R 47 may be the same or different from each other, and R 33 to R 47 each independently represent a hydrogen atom,
Figure 112013058279111-pat00034
, A substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, or a substituted or unsubstituted C1 to C30 heterocycloalkyl group,

R51 내지 R54는 서로 같거나 다를 수 있고, R51 내지 R54는 각각 독립적으로 수소원자, 치환 또는 비치환된 C1 내지 C30 알킬기, 치환 또는 비치환된 C3 내지 C30 시클로알킬기, 치환 또는 비치환된 C1 내지 C30 헤테로시클로알킬기, 치환 또는 비치환된 C6 내지 C30 아릴기, 또는 치환 또는 비치환된 C1 내지 C30 헤테로아릴기일 수 있다.R 51 to R 54 may be the same or different from each other and each of R 51 to R 54 independently represents a hydrogen atom, a substituted or unsubstituted C1 to C30 alkyl group, a substituted or unsubstituted C3 to C30 cycloalkyl group, Substituted C1 to C30 heterocycloalkyl groups, substituted or unsubstituted C6 to C30 aryl groups, or substituted or unsubstituted C1 to C30 heteroaryl groups.

상기 치환 또는 비치환된 C6 내지 C30 아릴기의 예는 치환 또는 비치환된 페닐기, 치환 또는 비치환된 바이페닐기, 치환 또는 비치환된 터페닐기, 치환 또는 비치환된 나프탈레닐기, 치환 또는 비치환된 안트라세닐기, 치환 또는 비치환된 페난트레닐기, 치환 또는 비치환된 플루오레닐기, 치환 또는 비치환된 스파이로플루오레닐기, 치환 또는 비치환된 파이레닐기, 또는 치환 또는 비치환된 페릴레닐기일 수 있다.Examples of the substituted or unsubstituted C6 to C30 aryl group include a substituted or unsubstituted phenyl group, a substituted or unsubstituted biphenyl group, a substituted or unsubstituted terphenyl group, a substituted or unsubstituted naphthalenyl group, a substituted or unsubstituted naphthalenyl group, A substituted or unsubstituted phenanthrenyl group, a substituted or unsubstituted fluorenyl group, a substituted or unsubstituted spirobifluorenyl group, a substituted or unsubstituted pyrenyl group, or a substituted or unsubstituted furanyl group, Lt; / RTI >

상기 치환 또는 비치환된 C2 내지 C30 헤테로아릴기의 예는 치환 또는 비치환된 피리디닐기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 싸이오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 벤조싸이오페닐기, 치환 또는 비치환된 인돌릴기, 치환 또는 비치환된 이미다조[1,2-a]피리디닐기, 치환 또는 비치환된 벤지이미다졸릴기, 치환 또는 비치환된 인다졸릴기, 치환 또는 비치환된 페노티아지닐기, 치환 또는 비치환된 페나지닐기, 치환 또는 비치환된 카바졸릴기, 치환 또는 비치환된 디벤조싸이오페닐기, 치환 또는 비치환된 이미다졸릴기, 치환 또는 비치환된 트리아졸릴기, 치환 또는 비치환된 테트라졸릴기, 치환 또는 비치환된 옥사다이아졸릴기, 치환 또는 비치환된 옥사트리아졸릴기, 치환 또는 비치환된 싸이아트리아졸릴기, 치환 또는 비치환된 벤조트리아졸릴기, 치환 또는 비치환된 피라지닐기, 치환 또는 비치환된 피리다지닐기, 치환 또는 비치환된 퓨리닐기, 치환 또는 비치환된 퀴놀리닐기, 치환 또는 비치환된 이소퀴놀리닐기, 치환 또는 비치환된 프탈라지닐기, 치환 또는 비치환된 나프피리디닐기, 치환 또는 비치환된 퀴녹살리닐기, 치환 또는 비치환된 퀴나졸리닐기, 치환 또는 비치환된 아크리디닐기, 또는 치환 또는 비치환된 페난트롤리닐기, 바람직하게는 치환 또는 비치환된 피리디닐기, 치환 또는 비치환된 피리미디닐기, 치환 또는 비치환된 트리아지닐기, 치환 또는 비치환된 싸이오페닐기, 치환 또는 비치환된 피롤릴기, 치환 또는 비치환된 벤조싸이오페닐기, 치환 또는 비치환된 인돌릴기, 치환 또는 비치환된 이미다조[1,2-a]피리디닐기, 치환 또는 비치환된 벤지이미다졸릴기, 치환 또는 비치환된 인다졸릴기, 치환 또는 비치환된 페노티아지닐기, 치환 또는 비치환된 페나지닐기, 치환 또는 비치환된 카바졸릴기, 또는 치환 또는 비치환된 디벤조싸이오페닐기일 수 있다.Examples of the substituted or unsubstituted C2 to C30 heteroaryl group include a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted thiazinyl group, a substituted or unsubstituted thiophenyl group , A substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted indolyl group, a substituted or unsubstituted imidazo [1,2-a] pyridinyl group, a substituted or unsubstituted A substituted or unsubstituted indazolyl group, a substituted or unsubstituted phenothiazinyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted carbazolyl group, a substituted or unsubstituted dibenzoyl group, Substituted or unsubstituted imidazolyl groups, substituted or unsubstituted thiazolyl groups, substituted or unsubstituted tetrazolyl groups, substituted or unsubstituted oxadiazolyl groups, substituted or unsubstituted oxatriazolyl groups, However, A substituted or unsubstituted thiazolyl group, a substituted or unsubstituted benzothiazolyl group, a substituted or unsubstituted pyrazinyl group, a substituted or unsubstituted pyridazinyl group, a substituted or unsubstituted furyl group, a substituted or unsubstituted thiazolyl group, A substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted quinolinyl group, a substituted or unsubstituted quinoxalinyl group, a substituted or unsubstituted phthalazinyl group, a substituted or unsubstituted naphthyridinyl group, Or a substituted or unsubstituted phenanthrolinyl group, preferably a substituted or unsubstituted pyridinyl group, a substituted or unsubstituted pyrimidinyl group, a substituted or unsubstituted acridinyl group, a substituted or unsubstituted pyrazolinyl group, A substituted or unsubstituted thiazolyl group, a substituted or unsubstituted thiophenyl group, a substituted or unsubstituted pyrrolyl group, a substituted or unsubstituted benzothiophenyl group, a substituted or unsubstituted indolyl group, A substituted or unsubstituted benzothiazolyl group, a substituted or unsubstituted phenothiazyl group, a substituted or unsubstituted phenazinyl group, a substituted or unsubstituted benzothiazolyl group, , A substituted or unsubstituted carbazolyl group, or a substituted or unsubstituted dibenzothiophenyl group.

상기 유기전계발광소자용 화합물은 하기 화학식으로 표시되는 화합물 1 내지 86 중에서 선택된 어느 하나일 수 있다. The organic electroluminescent device compound may be any one selected from compounds 1 to 86 represented by the following formulas.

Figure 112013058279111-pat00035
Figure 112013058279111-pat00035

Figure 112013058279111-pat00036
Figure 112013058279111-pat00036

Figure 112013058279111-pat00037
Figure 112013058279111-pat00037

Figure 112013058279111-pat00038
Figure 112013058279111-pat00038

Figure 112013058279111-pat00039
Figure 112013058279111-pat00039

Figure 112013058279111-pat00040
Figure 112013058279111-pat00040

Figure 112013058279111-pat00041
Figure 112013058279111-pat00041

Figure 112013058279111-pat00042
Figure 112013058279111-pat00042

Figure 112013058279111-pat00043
Figure 112013058279111-pat00043

본 발명의 다른 측면에 따르면, 상기 유기전계발광소자용 화합물을 포함하는 유기전계발광소자가 제공될 수 있다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising the compound for an organic electroluminescent device.

본 발명의 또 다른 측면에 따르면, 제1전극, 제2전극 및 상기 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층을 포함하는 유기전계발광소자에 있어서, 상기 단수 또는 복수의 유기물층 중에서 선택된 1종 이상의 유기물층은 상기 유기전계발광소자용 화합물을 포함하는 것을 특징으로 하는 유기전계발광소자가 제공될 수 있다.According to another aspect of the present invention, there is provided an organic electroluminescent device comprising a first electrode, a second electrode, and a single or a plurality of organic layers between the first electrode and the second electrode, The organic electroluminescent device may further include at least one organic compound layer including the organic electroluminescent compound.

상기 단수 또는 복수의 유기물층은 발광층을 포함할 수 있다.The singular or plural organic layers may include a light emitting layer.

상기 복수의 유기물층은 발광층을 포함하고, 상기 복수의 유기물층은 전자주입층, 전자수송층, 정공차단층, 전자차단층, 정공수송층 및 정공주입층 중에서 선택된 1종 이상을 추가로 포함할 수 있다.The plurality of organic layers may include a light emitting layer, and the plurality of organic layers may further include at least one selected from an electron injecting layer, an electron transporting layer, a hole blocking layer, an electron blocking layer, a hole transporting layer, and a hole injecting layer.

상기 발광층은 호스트와 도펀트를 포함할 수 있다.The light emitting layer may include a host and a dopant.

본 발명은 전기적 안정성 및 전자와 홀 수송능력이 우수하며, 삼중항 상태 에너지가 높아 인광발광재료의 발광효율을 향상시킬 수 있는 호스트로서 발광층에 사용 될 수 있는 유기전계발광소자용 화합물 및 이를 포함하는 유기전기발광소자를 제공할 수 있다.The present invention relates to a compound for an organic electroluminescent device which can be used for a light emitting layer as a host which is excellent in electrical stability and electron and hole transporting ability and has high triplet state energy and can improve the luminous efficiency of a phosphorescent light emitting material, An organic electroluminescent device can be provided.

또한 본 발명은 유기전계발광소자의 전자수송재료나, 정공수송재료에 사용될 수 있는 유기전계발광소자용 화합물 및 이를 포함하는 유기전계발광소자를 제공할 수 있다.In addition, the present invention can provide an organic electroluminescent compound which can be used for an electron transporting material and a hole transporting material of an organic electroluminescent device, and an organic electroluminescent device including the same.

도 1은 본 발명의 일 실시예에 따른 유기전계발광소자의 단면을 나타낸 단면도이다.
도 2는 본 발명의 다른 일 실시예에 따른 유기전계발광소자의 단면을 나타낸 단면도이다.
1 is a cross-sectional view illustrating an organic electroluminescent device according to an embodiment of the present invention.
2 is a cross-sectional view illustrating an organic electroluminescent device according to another embodiment of the present invention.

본 발명은 다양한 변환을 가할 수 있고 여러 가지 실시예를 가질 수 있는 바, 특정 실시예들을 예시하고 상세한 설명에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 실시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변환, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 발명을 설명함에 있어서 관련된 공지 기술에 대한 구체적인 설명이 본 발명의 요지를 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.The invention is capable of various modifications and may have various embodiments, and particular embodiments are exemplified and will be described in detail in the detailed description. It is to be understood, however, that the invention is not to be limited to the specific embodiments, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

또한, 이하에서 사용될 제1, 제2 등과 같이 서수를 포함하는 용어는 다양한 구성요소들을 설명하는데 사용될 수 있지만, 상기 구성요소들은 상기 용어들에 의해 한정되지는 않는다. 상기 용어들은 하나의 구성요소를 다른 구성요소로부터 구별하는 목적으로만 사용된다. 예를 들어, 본 발명의 권리 범위를 벗어나지 않으면서 제1 구성요소는 제2 구성요소로 명명될 수 있고, 유사하게 제2 구성요소도 제1 구성요소로 명명될 수 있다. Furthermore, terms including an ordinal number such as first, second, etc. to be used below can be used to describe various elements, but the constituent elements are not limited by the terms. The terms are used only for the purpose of distinguishing one component from another. For example, without departing from the scope of the present invention, the first component may be referred to as a second component, and similarly, the second component may also be referred to as a first component.

또한, 어떤 구성요소가 다른 구성요소 상에 "형성되어" 있다거나 "적층되어" 있다고 언급된 때에는, 그 다른 구성요소의 표면 상의 전면 또는 일면에 직접 부착되어 형성되어 있거나 적층되어 있을 수도 있지만, 중간에 다른 구성요소가 더 존재할 수도 있다고 이해되어야 할 것이다.Also, when an element is referred to as being "formed" or "laminated" on another element, it may be directly attached or laminated to the front surface or one surface of the other element, It will be appreciated that other components may be present in the < / RTI >

단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서상에 기재된 특징, 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성요소, 부품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다.The singular expressions include plural expressions unless the context clearly dictates otherwise. In the present application, the terms "comprises" or "having" and the like are used to specify that there is a feature, a number, a step, an operation, an element, a component or a combination thereof described in the specification, But do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, or combinations thereof.

본 명세서에서 "원자가결합"이란 별도의 정의가 없는 한, 단일결합, 이중결합 또는 삼중결합을 의미한다.As used herein, "atomic bond" means a single bond, a double bond or a triple bond, unless otherwise defined.

본 명세서에서 "치환"이란 별도의 정의가 없는 한, 치환기 또는 화합물 중의 적어도 하나의 수소가 중수소, 할로겐기, 히드록시기, 아미노기, C1 내지 C30 아민기, 니트로기, C1 내지 C30 실릴기, C1 내지 C30 알킬기, C1 내지 C30 알킬실릴기, C3 내지 C30 시클로알킬기, C1 내지 C30 헤테로시클로알킬기, C6 내지 C30 아릴기, C1 내지 C30 헤테로 아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기 또는 시아노기로 치환된 것을 의미한다.As used herein, unless otherwise defined, "substituent" means that at least one hydrogen in the substituent or compound is substituted with one or more substituents selected from the group consisting of deuterium, a halogen group, a hydroxy group, an amino group, a C1 to C30 amine group, a nitro group, a C1 to C30 silyl group, An alkyl group, a C1 to C30 alkylsilyl group, a C3 to C30 cycloalkyl group, a C1 to C30 heterocycloalkyl group, a C6 to C30 aryl group, a C1 to C30 heteroaryl group, a C1 to C20 alkoxy group, a C1 to C10 trifluoroalkyl group, It means that it has been replaced by anger.

또한 상기 치환된 할로겐기, 히드록시기, 아미노기, C1 내지 C30 아민기, C3 내지 C30 실릴기, C1 내지 C30 알킬기, C1 내지 C30 알킬실릴기, C3 내지 C30 시클로알킬기, C6 내지 C30 아릴기, C1 내지 C20 알콕시기, C1 내지 C10 트리플루오로알킬기 또는 시아노기 중 인접한 두 개의 치환기가 융합되어 고리를 형성할 수도 있다.A C1 to C30 alkyl group, a C1 to C30 alkylsilyl group, a C3 to C30 cycloalkyl group, a C6 to C30 aryl group, a C1 to C20 aryl group, a C1 to C30 aryl group, a C1 to C30 aryl group, An alkoxy group, a C1 to C10 trifluoroalkyl group or a cyano group may be fused to form a ring.

본 명세서에서 "헤테로"란 별도의 정의가 없는 한, 하나의 작용기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로 원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다.As used herein, unless otherwise defined, it is meant that one functional group contains 1 to 4 heteroatoms selected from the group consisting of N, O, S, and P, and the remainder is carbon.

본 명세서에서 "이들의 조합"이란 별도의 정의가 없는 한, 둘 이상의 치환기가 연결기로 결합되어 있거나, 둘 이상의 치환기가 축합하여 결합되어 있는 것을 의미한다.In the present specification, the term "combination thereof" means that two or more substituents are bonded to each other via a linking group or two or more substituents are condensed and bonded.

본 명세서에서 "수소"란 별도의 정의가 없는 한, 일중수소, 이중수소, 또는 삼중수소를 의미한다. As used herein, "hydrogen" means monohydrogen, double hydrogen, or tritium, unless otherwise defined.

본 명세서에서 "알킬(alkyl)기"란 별도의 정의가 없는 한, 지방족 탄화수소기를 의미한다. As used herein, unless otherwise defined, the term "alkyl group" means an aliphatic hydrocarbon group.

알킬기는 어떠한 이중결합이나 삼중결합을 포함하고 있지 않은 "포화 알킬(saturated alkyl)기" 일 수 있다. The alkyl group may be a "saturated alkyl group" which does not contain any double or triple bonds.

알킬기는 적어도 하나의 이중결합 또는 삼중결합을 포함하고 있는 "불포화 알킬(unsaturated alkyl)기"일 수도 있다. The alkyl group may be an "unsaturated alkyl group" comprising at least one double bond or triple bond.

"알케닐렌(alkenylene)기"는 적어도 두 개의 탄소원자가 적어도 하나의 탄소-탄소 이중 결합으로 이루어진 작용기를 의미하며, "알키닐렌(alkynylene)기" 는 적어도 두 개의 탄소원자가 적어도 하나의 탄소-탄소 삼중 결합으로 이루어진 작용기를 의미한다. 포화이든 불포화이든 간에 알킬기는 분지형, 직쇄형 또는 환형일 수 있다. "Alkynylene group" means a functional group in which at least two carbon atoms are composed of at least one carbon-carbon double bond, and "alkynylene group" means that at least two carbon atoms have at least one carbon- Quot; means a functional group formed by bonding. The alkyl group, whether saturated or unsaturated, can be branched, straight chain or cyclic.

알킬기는 C1 내지 C30 알킬기일 수 있다. 보다 구체적으로 알킬기는 C1 내지 C20 알킬기, C1 내지 C10 알킬기 또는 C1 내지 C6 알킬기일 수도 있다.The alkyl group may be a C1 to C30 alkyl group. More specifically, the alkyl group may be a C1 to C20 alkyl group, a C1 to C10 alkyl group or a C1 to C6 alkyl group.

예를 들어, C1 내지 C4 알킬기는 알킬쇄에 1 내지 4 개의 탄소원자, 즉, 알킬쇄는 메틸, 에틸, 프로필, 이소-프로필, n-부틸, 이소-부틸, sec-부틸 및 t-부틸로 이루어진 군에서 선택됨을 나타낸다.For example, the C1 to C4 alkyl groups may have 1 to 4 carbon atoms in the alkyl chain, i.e., the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of methyl, ethyl, propyl, iso-propyl, n-butyl, Indicating that they are selected from the group.

구체적인 예를 들어 상기 알킬기는 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, 이소부틸기, t-부틸기, 펜틸기, 헥실기, 에테닐기, 프로페닐기, 부테닐기, 시클로프로필기, 시클로부틸기, 시클로펜틸기, 시클로헥실기 등을 의미한다.Specific examples of the alkyl group include a methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, t-butyl group, pentyl group, hexyl group, ethenyl group, Butyl group, cyclopentyl group, cyclohexyl group, and the like.

"아민기"는 아릴아민기, 알킬아민기, 아릴알킬아민기, 또는 알킬아릴아민기를 포함한다.The "amine group" includes an arylamine group, an alkylamine group, an arylalkylamine group, or an alkylarylamine group.

"시클로알킬(cycloalkyl)기"는 모노시클릭 또는 융합고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다."Cycloalkyl group" includes monocyclic or fused-ring polycyclic (i. E., Rings that divide adjacent pairs of carbon atoms) functional groups.

"헤테로시클로알킬(heterocycloalkyl)기"는 시클로알킬기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다. 상기 헤테로시클로알킬기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 4개 포함할 수 있다."Heterocycloalkyl group" means that the cycloalkyl group contains 1 to 4 hetero atoms selected from the group consisting of N, O, S and P in the cycloalkyl group, and the remainder is carbon. When the heterocycloalkyl group is a fused ring, it may contain 1 to 4 heteroatoms in each ring.

"방향족(aromatic)기"는 고리 형태인 작용기의 모든 원소가 p-오비탈을 가지고 있으며, 이들 p-오비탈이 공액(conjugation)을 형성하고 있는 작용기를 의미한다. 구체적인 예로 아릴기와 헤테로아릴기가 있다. "An aromatic group" means a functional group in which all elements of a functional group in the form of a ring have a p-orbital, and these p-orbital forms a conjugation. Specific examples thereof include an aryl group and a heteroaryl group.

"아릴(aryl)기"는 모노시클릭 또는 융합 고리 폴리시클릭(즉, 탄소원자들의 인접한 쌍들을 나눠 가지는 고리) 작용기를 포함한다. An "aryl group" includes a monocyclic or fused ring polycyclic (i. E., A ring that divides adjacent pairs of carbon atoms) functional groups.

"헤테로아릴(heteroaryl)기"는 아릴기 내에 N, O, S 및 P로 이루어진 군에서 선택되는 헤테로원자를 1 내지 4개 함유하고, 나머지는 탄소인 것을 의미한다. 상기 헤테로아릴기가 융합고리인 경우, 각각의 고리마다 상기 헤테로 원자를 1 내지 4개 포함할 수 있다. "Heteroaryl group" means that the aryl group contains 1 to 4 hetero atoms selected from the group consisting of N, O, S and P, and the remainder is carbon. When the heteroaryl group is a fused ring, it may contain 1 to 4 heteroatoms in each ring.

아릴기 및 헤테로아릴기에서 고리의 원자수는 탄소수 및 비탄소원자수의 합이다.In the aryl group and the heteroaryl group, the number of atoms in the ring is the sum of carbon number and non-carbon atom number.

"알킬아릴기" 또는 "아릴알킬기"와 같이 조합하여 사용할 때, 상기에 든 각각의 알킬 및 아릴의 용어는 상기 나타낸 의미와 내용을 가진다.When used in combination, such as "alkylaryl" or "arylalkyl group ", the terms alkyl and aryl of each of the above have the meanings and contents indicated above.

"아릴알킬기"이란 용어는 벤질과 같은 아릴 치환된 알킬 라디칼을 의미하며 알킬기에 포함된다.The term "arylalkyl group " means an aryl substituted alkyl radical, such as benzyl, and is included in the alkyl group.

"알킬아릴기"이란 용어는 알킬 치환된 아릴 라디칼을 의미하며 아릴기에 포함된다.The term "alkylaryl group " means an alkyl substituted aryl radical and is included in the aryl group.

이하, 본 발명의 실시예를 첨부도면을 참조하여 설명하기로 하며, 첨부 도면을 참조하여 설명함에 있어, 동일하거나 대응하는 구성 요소는 동일한 도면번호를 부여하고 이에 대한 중복되는 설명은 생략하기로 한다.DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings. Referring to the accompanying drawings, the same or corresponding components are denoted by the same reference numerals, .

도 1 및 2를 참고하면, 본 발명의 실시예에 따르면 본 발명에 따른 유기전계발광소자용 화합물을 포함하는 유기전계발광소자(1)가 제공될 수 있다.Referring to FIGS. 1 and 2, an organic electroluminescent device 1 including the compound for an organic electroluminescent device according to the present invention can be provided according to an embodiment of the present invention.

본 발명의 다른 실시예에 따르면, 상기 유기전계발광소자는 제1전극(110); 제2전극(150); 및 상기 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층(130)을 포함하며, 상기 단수 또는 복수의 유기물층(130) 중에서 선택된 1종 이상의 유기물층은 본 발명에 따른 유기발광소자용 화합물을 포함할 수 있다.According to another embodiment of the present invention, the organic electroluminescent device includes a first electrode 110; A second electrode (150); And one or more organic layers 130 between the first and second electrodes and at least one organic layer selected from the single or plurality of organic layers 130 include the compound for an organic light emitting device according to the present invention can do.

여기서, 상기 단수 또는 복수의 유기물층(130)은 발광층(134)을 포함할 수 있다. Here, the single or plural organic layers 130 may include a light emitting layer 134.

또한 상기 복수의 유기물층(130)은 발광층(134)을 포함하고, 상기 복수의 유기물층은 전자주입층(131), 전자수송층(132), 정공차단층(133), 전자차단층(135), 정공수송층(136) 및 정공주입층(137) 중에서 선택된 1종 이상을 추가로 포함할 수 있다.The plurality of organic layers 130 may include a light emitting layer 134 and the plurality of organic layers may include an electron injection layer 131, an electron transport layer 132, a hole blocking layer 133, an electron blocking layer 135, Transporting layer 136 and hole-injecting layer 137 may be further included.

상기 발광층(134)은 호스트와 도펀트를 포함할 수 있다.The light emitting layer 134 may include a host and a dopant.

상기 유기전계발광소자는 바람직하게는 투명기판에 의하여 지지된다. 투명기판의 재료로는 양호한 기계적 강도, 열안정성 및 투명성을 갖는 한 특별한 제한은 없다. 구체적인 예를 들면, 유리, 투명 플라스틱 필름 등을 사용할 수 있다.The organic electroluminescent device is preferably supported by a transparent substrate. The material of the transparent substrate is not particularly limited as long as it has good mechanical strength, thermal stability and transparency. Specific examples thereof include glass, transparent plastic film, and the like.

본 발명의 유기전계발광소자의 양극재료로서는 4eV 이상의 일함수를 갖는 금속, 합금, 전기전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는 금속인 Au 또는 CuI, ITO(인듐 주석 산화물), SnO2 및 ZnO와 같은 투명 전도성 재료를 들 수 있다. 양극 필름의 두께는 10 내지 200nm 가 바람직하다.As the cathode material of the organic electroluminescent device of the present invention, a metal, an alloy, an electroconductive compound or a mixture thereof having a work function of 4 eV or more can be used. Specifically, transparent conductive materials such as Au or CuI, ITO (indium tin oxide), SnO 2 and ZnO, which are metals, can be mentioned. The thickness of the positive electrode film is preferably 10 to 200 nm.

본 발명의 유기전계발광소자의 음극 재료로서는 4eV 미만의 일함수를 갖는 금속, 합금, 전기 전도성 화합물 또는 이의 혼합물을 사용할 수 있다. 구체적으로는, Na, Na-K 합금, 칼슘, 마그네슘, 리튬, 리튬 합금, 인듐, 알루미늄, 마그네슘 합금, 알루미늄 합금을 들 수 있다. 이외에, 알루미늄/AlO2, 알루미늄/리튬, 마그네슘/은 또는 마그네슘/인듐 등도 사용될 수 있다. 음극필름의 두께는 10 내지 200nm 가 바람직하다.As the anode material of the organic electroluminescent device of the present invention, a metal, an alloy, an electrically conductive compound or a mixture thereof having a work function of less than 4 eV may be used. Specifically, Na, Na-K alloy, calcium, magnesium, lithium, lithium alloy, indium, aluminum, magnesium alloy and aluminum alloy can be mentioned. In addition, aluminum / AlO 2 , aluminum / lithium, magnesium / silver or magnesium / indium may be used. The thickness of the negative electrode film is preferably 10 to 200 nm.

유기 EL 소자의 발광효율을 높이기 위해서는 하나 이상의 전극은 바람직하게는 10% 이상의 광투과율을 가지는 것이 바람직하다. 전극의 쉬트저항은 바람직하게는 수백 Ω/mm 이하이다. 전극의 두께는 10nm 내지 1㎛, 보다 바람직하게는 10 내지 400nm 이다. 이러한 전극은 화학적 기상증착(CVD), 물리적 기상증착(PVD) 등의 기상증착법 또는 스퍼터링법을 통하여 상기한 전극 재료를 박막으로 형성하여 제조할 수 있다.In order to increase the luminous efficiency of the organic EL device, at least one electrode preferably has a light transmittance of 10% or more. The sheet resistance of the electrode is preferably several hundreds? / Mm or less. The thickness of the electrode is 10 nm to 1 탆, more preferably 10 to 400 nm. Such an electrode can be manufactured by forming the electrode material into a thin film by a vapor deposition method such as chemical vapor deposition (CVD) or physical vapor deposition (PVD) or a sputtering method.

또한 본 발명의 목적에 적합하게 본 발명의 유기전계발광소자용 화합물이 사용될 때, 공지된 정공수송 물질, 정공주입 물질, 발광층 물질, 발광층의 호스트 물질, 전자수송 물질, 및 전자주입 물질이 상기 각각의 유기물층에서 단독으로 사용되거나 또는 본 발명의 유기전계발광소자용 화합물과 선택적으로 병행하여 사용될 수 있다.When the compound for an organic electroluminescence device of the present invention is used for the purpose of the present invention, the known hole transporting material, hole injecting material, light emitting layer material, host material of the light emitting layer, electron transporting material, Or may be used in combination with the organic electroluminescent device compound of the present invention selectively.

정공 수송 물질로서 N,N-dicarbazolyl-3,5-benzene(mCP), poly(3,4-ethylenedioxythiophene):polystyrenesulfonate (PEDOT:PSS), N, N’-di(1-naphthyl)-N,N’-diphenylbenzidine(NPD), N,N'-디페닐-N,N'-디(3-메틸페닐)-4,4'-디아미노비페닐(TPD), N,N'-디페닐-N,N'-디나프틸-4,4'-디아미노비페닐, N,N,N'N'-테트라-p-톨릴-4,4'-디아미노비페닐, N,N,N'N'-테트라페닐-4,4'-디아미노비페닐, 코퍼(II)1,10,15,20-테트라페닐-21H,23H-포피린 등과 같은 포피린(porphyrin)화합물 유도체, 주쇄 또는 측쇄내에 방향족 3차아민을 갖는 중합체, 1,1-비스(4-디-p-톨릴아미노페닐)시클로헥산, N,N,N-트리(p-톨릴)아민, 4, 4', 4'-트리스[N-(3-메틸페닐)-N-페닐아미노]트리페닐아민과 같은 트리아릴아민 유도체, N-페닐카르바졸 및 폴리비닐카르바졸과 같은 카르바졸 유도체, 무금속 프탈로시아닌, 구리프탈로시아닌과 같은 프탈로시아닌 유도체, 스타버스트 아민 유도체, 엔아민스틸벤계 유도체, 방향족 삼급아민과 스티릴 아민 화합물의 유도체, 및 폴리실란 등을 들 수 있다.N-dicarbazolyl-3,5-benzene (mCP), poly (3,4-ethylenedioxythiophene): polystyrenesulfonate (PEDOT: PSS), N, N'- (NPD), N, N'-diphenyl-N, N'-di (3-methylphenyl) -4,4'- diaminobiphenyl (TPD) N, N'N'-tetra-p-tolyl-4,4'-diaminobiphenyl, N, N'N'N'N'- Porphyrin compound derivatives such as tetraphenyl-4,4'-diaminobiphenyl, copper (II) 1,10,15,20-tetraphenyl-21H, 23H-porphyrin and the like, aromatic tertiary (4-di-p-tolylaminophenyl) cyclohexane, N, N, N-tri (3-methylphenyl) -N-phenylamino] triphenylamine, carbazole derivatives such as N-phenylcarbazole and polyvinylcarbazole, phthalocyanine derivatives such as nonmetal phthalocyanine and copper phthalocyanine, An aminostilbene derivative, a derivative of an aromatic tertiary amine and a styrylamine compound, and polysilane.

전자 수송 물질로서 diphenylphosphine oxide-4-(triphenylsilyl)phenyl (TSPO1), Alq3, 2,5-디아릴 실롤 유도체(PyPySPyPy), 퍼플루오리네이티드 화합물(PF-6P), Octasubstituted cyclooctatetraene 화합물(COTs)을 들 수 있다.The diphenylphosphine oxide-4- (triphenylsilyl) phenyl (TSPO1), Alq 3, 2,5- diaryl silole derivatives (PyPySPyPy), perfluoro rineyi suited compound (PF-6P), Octasubstituted cyclooctatetraene compound (COTs) as an electron transport material .

본 발명의 유기전계발광소자에 있어서, 전자 주입층, 전자 수송층, 정공 수송층 및 정공 주입층은 상기한 화합물의 하나 이상의 종류를 함유하는 단일 층으로 형성되거나, 또는 상호 적층된, 상이한 종류의 화합물을 함유하는 복수의 층으로 구성될 수 있다.In the organic electroluminescent device of the present invention, the electron injecting layer, the electron transporting layer, the hole transporting layer, and the hole injecting layer may be formed of a single layer containing at least one kind of the above-mentioned compounds, And the like.

발광재료로서 예를 들면 축광 형광재료, 형광증백제, 레이저 색소, 유기 신틸레이터 및 형광 분석용 시약을 들 수 있다. 구체적으로는, 카바졸계 화합물, 포스핀옥사이드계 화합물, 카바졸계 포스핀옥사이드 화합물, bis((3,5-difluoro-4-cyanophenyl)pyridine) iridium picolinate(FCNIrpic), tris(8-hydroxyquinoline) aluminum(Alq3), 안트라센, 페난트렌, 피렌, 크리센, 페릴렌, 코로넨, 루브렌 및 퀴나크리돈과 같은 폴리아로마틱 화합물, 퀴터페닐과 같은 올리고페닐렌 화합물, 1,4-비스 (2-메틸스티릴)벤젠, 1,4-비스(4-메틸스티릴)벤젠, 1,4-비스(4-메틸-5-페닐-2-옥사졸릴)벤젠, 1,4-비스(5-페닐-2-옥사졸릴)벤젠, 2,5-비스(5-t-부틸-2-벤즈옥사졸릴)사이오펜, 1,4-디페닐-1,3-부타디엔, 1,6-디페닐-1,3,5-헥사트리엔,1,1,4,4-테트라페닐-1,3-부타디엔과 같은 액체신틸레이션용 신틸레이터, 옥신 유도체의 금속착체, 쿠마린 색소, 디시아노메틸렌피란 색소, 디시아노메틸렌사이오피란 색소, 폴리메틴 색소, 옥소벤즈안트라센 색소, 크산텐 색소, 카르보스티릴 색소, 페릴렌 색소, 옥사진 화합물, 스틸벤 유도체, 스피로 화합물, 옥사디아졸 화합물 등을 들 수 있다.Examples of the light emitting material include a phosphorescent fluorescent material, a fluorescent whitening agent, a laser dye, an organic scintillator, and a reagent for fluorescence analysis. Specifically, a carbazole compound, a phosphine oxide compound, a carbazole-based phosphine oxide compound, bis (3,5-difluoro-4-cyanophenyl) pyridine, iridium picolinate (FCNIrpic), tris (8-hydroxyquinoline) aluminum Alq 3 ), polyaromatic compounds such as anthracene, phenanthrene, pyrene, chrysene, perylene, coronene, rubrene and quinacridone, oligophenylene compounds such as quaterphenyl, 1,4- Bis (4-methylstyryl) benzene, 1,4-bis (4-methyl- Bis (5-t-butyl-2-benzoxazolyl) thiophene, 1,4-diphenyl-1,3-butadiene, 1,6- Liquid scintillation scintillators such as 3,5-hexatriene and 1,1,4,4-tetraphenyl-1,3-butadiene, metal complexes of oxine derivatives, coumarin dyes, dicyanomethylenepyran dyes, dicyanomethylene Cyopyran pigment, polymethine pigment, oxobenzanthracene There may be mentioned a colorant, a xanthene colorant, a carbostyryl colorant, a perylene colorant, an oxazine compound, a stilbene derivative, a spiro compound, and an oxadiazole compound.

본 발명의 유기 EL 소자를 구성하는 각 층은 진공 증착, 스핀 코팅 또는 캐스팅과 같은 공지된 방법을 통하여 박막으로 형성시키거나, 각 층에서 사용되는 재료를 이용하여 제조할 수 있다. 이들 각층의 막 두께에 대해서는 특별한 제한은 없으며, 재료의 특성에 따라 알맞게 선택할 수 있으나, 보통 2nm 내지 5,000nm의 범위에서 결정될 수 있다.Each layer constituting the organic EL device of the present invention can be formed into a thin film through a known method such as vacuum deposition, spin coating or casting, or can be manufactured using a material used in each layer. The thickness of each of these layers is not particularly limited and may be appropriately selected according to the characteristics of the material, but may be determined usually in the range of 2 nm to 5,000 nm.

본 발명의 따른 유기전계발광소자용 화합물은 진공 증착법에 의하여 형성될 수 있으므로, 박막 형성 공정이 간편하고, 핀홀(pin hole)이 거의 없는 균질한 박막으로 용이하게 얻을 수 있는 장점이 있다.
The compound for an organic electroluminescence device according to the present invention can be formed by a vacuum deposition method, so that it is advantageous that a thin film forming process is simple and a homogeneous thin film having almost no pinhole can be easily obtained.

[실시예][Example]

이하, 실시예를 통하여 본 발명에 따른 유기전계발광소자용 화합물 및 이를 포함하는 유기전계발광소자의 제조방법을 더욱 구체적으로 설명한다. 그러나 이는 예시를 위한 것으로서 이에 의하여 본 발명의 범위가 한정되는 것이 아니다.Hereinafter, the compound for an organic electroluminescent device according to the present invention and the method for manufacturing the organic electroluminescent device including the same will be described in more detail with reference to the following examples. However, this is for the purpose of illustration only and is not intended to limit the scope of the invention.

실시예Example 1: 화합물 1 합성 1: Synthesis of compound 1

(1) (One) 제조예Manufacturing example 1-1: 중간체 1-1 합성 1-1: Intermediate 1-1 Synthesis

Figure 112013058279111-pat00044
Figure 112013058279111-pat00044

3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol/중국산)에 3-bromo-4'-iodobiphenyl(8.4g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol/P&H TECH), potassium carbonate(9.5g, 0.069mol/sigma Aldrich)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 1-1을 9.3g(수율 75%) 수득하였다.3-bromo-4'-iodobiphenyl (8.4 g, 0.023 mol / sigma Aldrich) was added to 3- (4,6-diphenyl-1,3,5-triazin- 2- yl) phenylboronic acid (10.0 g, 0.028 mol / 400 ml of THF was added to Pd (PPh3) 4 (1.3 g, 0.0011 mol / P & H TECH) and potassium carbonate (9.5 g, 0.069 mol / sigma Aldrich) and reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 9.3 g (yield 75%) of Intermediate 1-1.

LC/MS: m/z=540 [(M+1)+]LC / MS: m / z = 540 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 1-2: 화합물 1 합성 1-2: Compound 1 synthesis

Figure 112013058279111-pat00045
Figure 112013058279111-pat00045

중간체 1-1(10.0g, 0.018mol)에 9H-carbazole(3.6g, 0.021mol/sigma Aldrich), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 1을 8.1g(수율 71%) 수득하였다.Pd (PPh3) 4 (1.0 g, 0.0009 mol) and potassium carbonate (7.5 g, 0.054 mol) were added to a solution of 9H-carbazole (3.6 g, 0.021 mol / sigma Aldrich), Intermediate 1-1 (10.0 g, 0.018 mol) And the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.1 g (yield: 71%) of Compound 1.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.70/D, 8.24/D, 7.57/M, 7.48/D, 7.52/D, 8.09/D, 7.46/D, 7.63/D, 7.50/M, 7.29/M, 8.12/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D) 2H(7.41/M) 4H(7.05/D, 8.28/D) 5H(7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.70 / D, 8.24 / D, 7.57 / M, 7.48 / D, 7.52 / D, 8.09 / D, 7.46 / D, 7.63 / D, 7.50 / M (7.21 / M, 8.12 / D, 8.55 / D, 7.25 / M, 7.33 / M, 7.94 / D)

LC/MS: m/z=627 [(M+1)+]LC / MS: m / z = 627 [(M + 1) < + &

실시예Example 2: 화합물 5 합성 2: Compound 5 Synthesis

Figure 112013058279111-pat00046
Figure 112013058279111-pat00046

중간체 1-1(10.0g, 0.018mol)에 5H-pyrazino[2,3-b]indole(3.6g, 0.021mol/sigma aldrich), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 5를8.0g(수율 71%) 수득하였다.To a solution of Intermediate 1-1 (10.0 g, 0.018 mol) was added 5H-pyrazino [2,3-b] indole (3.6 g, 0.021 mol / sigma aldrich), Pd (PPh3) 4 (1.0 g, 0.0009 mol) 7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.0 g (yield: 71%) of Compound 5.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.24/D, 7.57/M, 7.48/D, 7.70/S, 8.09/S, 7.52/D, 7.51/M, 7.46/D, 7.94/D, 7.33/M, 7.25/M, 8.74/D) 2H(7.41/M, 8.63/D) 4H(7.25/D, 8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.24 / D, 7.57 / M, 7.48 / D, 7.70 / S, 8.09 / S, 7.52 / D, 7.51 / M, 7.46 / D, 7.94 / D M, 8.63 / D) 4H (7.25 / D, 8.28 / D, 7.51 / M)

LC/MS: m/z=629 [(M+1)+] LC / MS: m / z = 629 [(M + 1) < + &

실시예Example 3: 화합물 6 합성 3: Synthesis of Compound 6

Figure 112013058279111-pat00047
Figure 112013058279111-pat00047

중간체 1-1(10.0g, 0.018mol)에 9H-pyrido[2,3-b]indole (3.6g, 0.021mol/sigma aldrich), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 6을 8.3g(수율 72%) 수득하였다.Pyrido [2,3-b] indole (3.6 g, 0.021 mol / sigma aldrich), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate 7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 8.3 g (yield: 72%) of Compound 6.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.48/D, 7.57/M, 8.24/D, 7.70/S, 7.52/D, 7.51/M, 7.46/D, 8.09/D, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 8.51/D, 7.36/M, 8.43/D) 2H(7.41/M) 4H(7.25/D, 8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.48 / D, 7.57 / M, 8.24 / D, 7.70 / S, 7.52 / D, 7.51 / M, 7.46 / D, 8.09 / D, 7.94 / D (7.25 / D, 8.28 / D, 7.51 / M), 7.33 / M, 7.25 / M, 8.55 / D, 8.51 / D, 7.36 /

LC/MS: m/z=628 [(M+1)+]LC / MS: m / z = 628 [(M + 1) < + &

실시예Example 4: 화합물 14 합성 4: Compound 14 Synthesis

Figure 112013058279111-pat00048
Figure 112013058279111-pat00048

중간체 1-1(10.0g, 0.018mol)에 5H-pyridazino[4,5-b]indole (3.6g, 0.021mol/sigma aldrich), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 14를 8.5g(수율 74%) 수득하였다.Pyridazino [4,5-b] indole (3.6 g, 0.021 mol / sigma aldrich), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate 7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, and subjected to column separation on H 2 O: MC, followed by column purification (n-hexane: MC) to obtain 8.5 g (yield: 74%) of Compound 14.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.48/D, 7.57/M, 8.24/D, 7.70/S, 7.52/D, 7.51/M, 7.46/D, 8.09/S, 7.94/D, 7.33/M, 7.25/M, 8.55/D) 2H(7.41/M, 9.24/S) 4H(7.25/D, 8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.48 / D, 7.57 / M, 8.24 / D, 7.70 / S, 7.52 / D, 7.51 / M, 7.46 / D, 8.09 / S, 7.94 / D (7.25 / D, 8.28 / D, 7.51 / M), 7.33 M, 7.25 M, 8.55 D) 2H (7.41 / M, 9.24 /

LC/MS: m/z=629 [(M+1)+] LC / MS: m / z = 629 [(M + 1) < + &

실시예Example 5: 화합물 2 합성 5: Synthesis of compound 2

(1) (One) 제조예Manufacturing example 5-1: 중간체 2-1 합성 5-1: Intermediate 2-1 Synthesis

Figure 112013058279111-pat00049
Figure 112013058279111-pat00049

3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid (10.0g, 0.028mol)에 4-bromo-4'-iodobiphenyl(8.4g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 2-1을 11.5g(수율 76%) 수득하였다.4-bromo-4'-iodobiphenyl (8.4g, 0.023mol / Sigma Aldrich) was added to 3- (4,6-diphenyl-1,3,5-triazin-2-yl) phenylboronic acid (10.0g, 0.028mol) 400 ml of THF was added to Pd (PPh3) 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 11.5 g (yield: 76%) of Intermediate 2-1.

LC/MS: m/z=540 [(M+1)+] LC / MS: m / z = 540 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 5-2: 화합물 2 합성 5-2: Synthesis of compound 2

Figure 112013058279111-pat00050
Figure 112013058279111-pat00050

중간체 2-1(10.0g, 0.018mol)에 9H-carbazole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 2를 8.1g(수율 72%) 수득하였다.400 ml of THF was added to 9 g-carbazole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol) and potassium carbonate (7.5 g, 0.054 mol) The mixture was stirred at 65 占 폚 for 18 hours to react. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.1 g (yield: 72%) of Compound 2.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.48/D, 7.57/M, 8.24/D, 7.70/S, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 8.12/D, 7.29/M, 7.50/M, 7.63/D) 2H(7.41/M, 7.79/D, 7.68/D) 4H(7.25/D, 8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.48 / D, 7.57 / M, 8.24 / D, 7.70 / S, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 8.12 / D , 7.29 / M, 7.50 / M, 7.63 / D) 2H (7.41 / M, 7.79 / D, 7.68 / D)

LC/MS: m/z=627 [(M+1)+] LC / MS: m / z = 627 [(M + 1) < + &

실시예Example 6: 화합물 16 합성 6: Compound 16 Synthesis

(1) (One) 제조예Manufacturing example 6-1: 중간체 16-1 합성 6-1: Synthesis of intermediate 16-1

Figure 112013058279111-pat00051
Figure 112013058279111-pat00051

3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 3-bromo-3'-iodobiphenyl(8.4g, 0.023mol), Pd(PPh3)4(1.3g, 0.0011mol/P&H TECH), potassium carbonate(9.5g, 0.069mol))에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 16-1을 8.8g(수율 71%) 수득하였다.3-bromo-3'-iodobiphenyl (8.4g, 0.023mol), Pd (PPh3) was added to 3- (4,6-diphenyl-1,3,5-triazin- ) 4 (1.3 g, 0.0011 mol / P & H TECH), potassium carbonate (9.5 g, 0.069 mol)) and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 8.8 g (yield: 71%) of intermediate 16-1.

LC/MS: m/z=540 [(M+1)+] LC / MS: m / z = 540 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 6-2: 화합물 16 합성 6-2: Compound 16 Synthesis

Figure 112013058279111-pat00052
Figure 112013058279111-pat00052

중간체 16-1(10.0g, 0.018mol)에 9H-carbazole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 16을 8.1g(수율 72%) 수득하였다.To the intermediate 16-1 (10.0 g, 0.018 mol) was added 400 mL of THF to 9H-carbazole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol) and potassium carbonate (7.5 g, 0.054 mol) The mixture was stirred at 65 占 폚 for 18 hours to react. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.1 g (yield 72%) of Compound 16.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.24/D, 7.52/D, 7.51/M, 7.46/D, 7.94/D, 7.33/M, 7.25/M, 8.55/D, 8.12/D, 7.29/M, 7.50/M, 7.63/D, 8.09/S) 2H(7.41/M, 7.70/S, 7.57/M) 3H(7.48/D) 4H(8.28/D, 7.51/M)D, 7.32 / D, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D, 8.12 / D (200 MHz, CDCl 3 ) (7.28 / D, 7.51 / M), 7.29 / M, 7.50 / M, 7.63 / D, 8.09 / S) 2H (7.41 / M, 7.70 /

LC/MS: m/z=627 [(M+1)+] LC / MS: m / z = 627 [(M + 1) < + &

실시예Example 7: 화합물 17 합성 7: Compound 17 Synthesis

Figure 112013058279111-pat00053
Figure 112013058279111-pat00053

중간체 16-1(10.0g, 0.018mol)에 9H-pyrido[2,3-b]indole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 17을 8.4g(수율 74%) 수득하였다.Pyrido [2,3-b] indole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate (7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.4 g (yield: 74%) of Compound 17.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.24/D, 8.09/S, 7.52/D, 7.51/M, 7.46/D, 8.43/D, 7.36/M, 8.51/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D) 2H(7.41/M, 7.70/D, 7.57/M) 3H(7.48/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.24 / D, 8.09 / S, 7.52 / D, 7.51 / M, 7.46 / D, 8.43 / D, 7.36 / M, 8.51 / D, 8.55 / D (7.48 / D, 7.57 / M) 3H (7.48 / D) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z=628 [(M+1)+] LC / MS: m / z = 628 [(M + 1) < + &

실시예Example 8: 화합물 18 합성 8: Compound 18 Synthesis

Figure 112013058279111-pat00054
Figure 112013058279111-pat00054

중간체 16-1(10.0g, 0.018mol)에 5H-pyridazino[4,5-b]indole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 18을 7.9g(수율 70%) 수득하였다.5H-pyridazino [4,5-b] indole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate (7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and column-purified (n-hexane: MC) to obtain 7.9 g (yield 70%) of Compound 18.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.24/D, 7.52/D, 7.51/M, 7.46/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D, 8.09/S) 2H(7.41/M, 7.70/S, 7.57/M, 9.24/S) 3H(7.48/D) 4H(8.28/D ,7.51/M ) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.24 / D, 7.52 / D, 7.51 / M, 7.46 / D, 8.55 / D, 7.25 / M, 7.33 / M, 7.94 / D, 8.09 / S ) H (7.48 / D) 4H (8.28 / D, 7.51 / M) 2H (7.41 / M, 7.70 / S, 7.57 / M, 9.24 /

LC/MS: m/z=629 [(M+1)+] LC / MS: m / z = 629 [(M + 1) < + &

실시예Example 9: 화합물 19 합성 9: Compound 19 Synthesis

Figure 112013058279111-pat00055
Figure 112013058279111-pat00055

중간체 16-1(10.0g, 0.018mol)에 5H-pyrazino[2,3-b]indole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 19를 8.0g(수율 71%) 수득하였다.5H-pyrazino [2,3-b] indole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate (7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 8.0 g (yield: 71%) of Compound 19.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.24/D, 7.52/D, 7.51/M, 7.46/D, 8.74/D, 7.25/M, 7.33/M, 7.94/D) 2H(7.41/M, 8.63/D, 7.70/S, 7.57/M) 3H(7.48/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.24 / D, 7.52 / D, 7.51 / M, 7.46 / D, 8.74 / D, 7.25 / M, 7.33 / M, 7.94 / D) 2H (7.41 (7.48 / D) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z=629 [(M+1)+] LC / MS: m / z = 629 [(M + 1) < + &

실시예Example 10: 화합물 47 합성 10: Compound 47 Synthesis

(1) (One) 제조예Manufacturing example 10-1: 중간체 47-1 합성 10-1: Intermediate 47-1 Synthesis

Figure 112013058279111-pat00056
Figure 112013058279111-pat00056

3-(4-phenyl-6-(pyridin-2-yl)-1,3,5-triazin-2-yl)phenylboronic acid (10.0g, 0.028mol/중국산)에 3-bromo-4'-iodobiphenyl(8.4g, 0.023mol) Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 47-1을 9.3g(수율 75%) 수득하였다.3-bromo-4'-iodobiphenyl (10.0 g, 0.028 mol) was added to 3- (4-phenyl-6- (pyridin-2-yl) -1,3,5-triazin- 400 ml of THF was added to Pd (PPh3) 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 9.3 g (yield 75%) of Intermediate 47-1.

(2) (2) 제조예Manufacturing example 10-2: 화합물 47 합성 10-2: Compound 47 Synthesis

Figure 112013058279111-pat00057
Figure 112013058279111-pat00057

중간체 47-1(10.0g, 0.018mol)에 5H-pyridazino[4,5-b]indole(3.6g, 0.021mol), Pd(PPh3)4(1.0g, 0.0009mol), potassium carbonate(7.5g, 0.054mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 47을 8.3g(수율 70%) 수득하였다.Pyridazino [4,5-b] indole (3.6 g, 0.021 mol), Pd (PPh3) 4 (1.0 g, 0.0009 mol), potassium carbonate (7.5 g, 0.054 mol), 400 ml of THF was added, and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 8.3 g (yield 70%) of Compound 47.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.59/D, 7.36/M, 7.85/M, 8.38/D, 7.41/M, 7.70/S, 8.24/D, 7.57/M, 7.48/D, 7.52/D, 7.51/M, 7.46/D, 8.09/S, 7.94/D, 7.33/M, 7.25/M, 8.55/D) 2H(8.28/D, 7.51/M, 9.24/S) 4H(7.25/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.59 / D, 7.36 / M, 7.85 / M, 8.38 / D, 7.41 / M, 7.70 / S, 8.24 / D, 7.57 / M, 7.48 / D 7.52 / D, 7.51 / M, 7.46 / D, 8.09 / S, 7.94 / D, 7.33 / M, 7.25 / M, 8.55 / D) 2H (8.28 / D, 7.51 / M, 9.24 / / D)

LC/MS: m/z=630 [(M+1)+] LC / MS: m / z = 630 [(M + 1) < + &

실시예Example 11: 화합물 76 합성 11: Synthesis of Compound 76

Figure 112013058279111-pat00058
Figure 112013058279111-pat00058

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid (10.0g, 0.028mol/중국산)에 2-bromotriphenylene(7.1g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 76을9.3g(수율 75%) 수득하였다.2-bromotriphenylene (7.1 g, 0.023 mol / sigma Aldrich) and Pd (PPh3) were added to 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenylboronic acid (10.0 g, 0.028 mol / ) 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol) were added 400 ml of THF and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 9.3 g (yield 75%) of 76.

H-NMR (200MHz, CDCl3):δ ppm, 1H(8.04/D, 8.18/D, 9.15/S) 2H(7.41/M, 7.85/D, 7.25/D, 7.88/M, 7.82/M, 8.12/D, 8.93/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (8.04 / D, 8.18 / D, 9.15 / S) 2H (7.41 / M, 7.85 / D, 7.25 / D, 7.88 / M, 7.82 / M, 8.12 / D, 8.93 / D) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z= 536 [(M+1)+] LC / MS: m / z = 536 [(M + 1) < + &

실시예Example 12: 화합물 77 합성 12: Compound 77 Synthesis

(1) (One) 제조예Manufacturing example 12-1: 중간체 77-1 합성 12-1: Synthesis of Intermediate 77-1

Figure 112013058279111-pat00059
Figure 112013058279111-pat00059

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 1,3-dibromo-5-iodobenzene(8.3g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 77-1을 9.1g(수율 71%) 수득하였다1,3-dibromo-5-iodobenzene (8.3 g, 0.023 mol / sigma Aldrich) was added to 4- (4,6-diphenyl-1,3,5-triazin- 2- yl) phenylboronic acid (10.0 g, 0.028 mol) , 400 g of Pd (PPh3) 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 9.1 g (yield: 71%) of Intermediate 77-1

LC/MS: m/z= 543 [(M+1)+]LC / MS: m / z = 543 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 12-2: 화합물 77 합성 12-2: Compound 77 Synthesis

Figure 112013058279111-pat00060
Figure 112013058279111-pat00060

중간체 77-1(10.0g, 0.018mol/중국산)에 3-(9H-carbazol-9-yl)phenylboronic acid(12.4g, 0.043mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 77을 11.2g(수율 72%) 수득하였다.3- (9H-carbazol-9-yl) phenylboronic acid (12.4g, 0.043mol / sigma Aldrich) and Pd (PPh3) 4 (1.3g, 0.0011mol) were added to Intermediate 77-1 (10.0g, 0.018mol / , potassium carbonate (9.5 g, 0.069 mol), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, subjected to column separation on H 2 O: MC and column-purified (n-hexane: MC) to obtain 11.2 g (yield 72%) of Compound 77.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.41/M, 7.85/D, 7.25/D, 7.52/D, 7.51/M, 7.46/D, 7.94/D, 7.25/M, 8.55/D, 8.12/D, 7.29/M, 8.09/S, 7.63/D) 3H(7.66/S) 4H(8.28/D, 7.51/M, 7.33/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.41 / M, 7.85 / D, 7.25 / D, 7.52 / D, 7.51 / M, 7.46 / D, 7.94 / D, 7.25 / M, 8.55 / D , 8.12 / D, 7.29 / M, 8.09 / S, 7.63 / D) 3H (7.66 /

LC/MS: m/z= 869[(M+1)+]LC / MS: m / z = 869 [(M + 1) < + &

실시예Example 13: 화합물 78 합성 13: Compound 78 Synthesis

Figure 112013058279111-pat00061
Figure 112013058279111-pat00061

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 2-bromo-9,9-diphenyl-9H-fluorene(9.1g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 78을 8.7g(수율 77%) 수득하였다.9-diphenyl-9H-fluorene (9.1 g, 0.023 mol) was added to 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenylboronic acid (10.0 g, 0.028 mol) (Sigma Aldrich), Pd (PPh3) 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol) were added 400 ml of THF and reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, subjected to column separation on H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 8.7 g (yield: 77%) of Compound 78.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.77/D, 7.63/D, 7.93/D, 7.87/D, 7.38/M, 7.28/M, 7.55/D) 2H(7.41/M, 7.85/D, 7.25/D, 7.26/M) 4H(8.28/D, 7.51/M, 7.33/M, 7.11/S) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.77 / D, 7.63 / D, 7.93 / D, 7.87 / D, 7.38 / M, 7.28 / M, 7.55 / D) 2H (7.41 / M, 7.85 / D, 7.25 / D, 7.26 / M) 4H (8.28 / D, 7.51 / M, 7.33 / M,

LC/MS: m/z= 626[(M+1)+]LC / MS: m / z = 626 [(M + 1) < + &

실시예Example 14: 화합물 79 합성 14: Compound 79 Synthesis

Figure 112013058279111-pat00062
Figure 112013058279111-pat00062

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 2-(3-bromophenyl)-1-phenyl-1H-benzo[d]imidazole(8.0g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 79를 11.5g(수율 71%) 수득하였다.To a solution of 2- (3-bromophenyl) -1-phenyl-lH-benzo [d] imidazole (10.0 g, 0.028 mol) was added to 4- (4,6-diphenyl-1,3,5-triazin- (8.0g, 0.023mol / Sigma Aldrich), Pd (PPh3) 4 (1.3g, 0.0011mol) and potassium carbonate (9.5g, 0.069mol) were added 400ml of THF and reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 11.5 g (yield: 71%) of Compound 79.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.57/M, 7.48/D, 7.70/S, 8.24/D, 7.59/D, 8.56/D, 7.45/M) 2H(7.41/M, 7.25/D, 7.85/D, 7.58/M, 7.50/D, 7.22/M) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.57 / M, 7.48 / D, 7.70 / S, 8.24 / D, 7.59 / D, 8.56 / D, 7.45 / M) 2H (7.41 / M, 7.25 7.58 / M, 7.50 / D, 7.22 / M) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z= 578[(M+1)+] LC / MS: m / z = 578 [(M + 1) < + &

실시예Example 15: 화합물 80 합성 15: Compound 80 Synthesis

(1) (One) 제조예Manufacturing example 15-1: 중간체 80-1 합성 15-1: Synthesis of Intermediate 80-1

Figure 112013058279111-pat00063
Figure 112013058279111-pat00063

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 32-bromo-6-(3-iodophenyl)pyridine(8.3g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol/P&H TECH), potassium carbonate(9.5g, 0.069mol/sigma Aldrich)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 80-1을 9.3g(수율75%) 수득하였다.Bromo-6- (3-iodophenyl) pyridine (8.3 g, 0.023 mol / l) was added to 4- (4,6-diphenyl-1,3,5-triazin- 400ml of THF was added to Pd (PPh3) 4 (1.3g, 0.0011mol / P & H TECH) and potassium carbonate (9.5g, 0.069mol / Sigma Aldrich) and reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 9.3 g (yield 75%) of Intermediate 80-1.

(2) (2) 제조예Manufacturing example 15-2: 화합물 80 합성 15-2: Compound 80 Synthesis

Figure 112013058279111-pat00064
Figure 112013058279111-pat00064

중간체 80-1(10.0g, 0.017mol)에 9H-carbazole(3.3g, 0.020mol) Pd(PPh3)4(1.0g, 0.0008mol), potassium carbonate(7.0g, 0.051mol)에 THF 300ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 80을 7.6g(수율 71%) 수득하였다.To the intermediate 80-1 (10.0 g, 0.017 mol) was added 300 ml of THF to 9H-carbazole (3.3 g, 0.020 mol) Pd (PPh3) 4 (1.0 g, 0.0008 mol) and potassium carbonate (7.0 g, 0.051 mol) C < / RTI > for 18 hours. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 7.6 g (yield: 71%) of Compound 80.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.44/M, 8.60/S, 8.30/D, 7.54/M, 7.52/D, 7.63/D, 7.50/M, 7.29/M, 8.12/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D) 2H(7.41/M, 8.81/D, 7.88/D, 6.86/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.44 / M, 8.60 / S, 8.30 / D, 7.54 / M, 7.52 / D, 7.63 / D, 7.50 / M, 7.29 / M, 8.12 / D (8.58 / D, 7.25 / M, 7.33 / M, 7.94 / D) 2H (7.41 / M, 8.81 / D, 7.88 / D, 6.86 / D)

LC/MS: m/z= 628[(M+1)+]LC / MS: m / z = 628 [(M + 1) < + &

실시예Example 16: 화합물 81 합성 16: Synthesis of compound 81

Figure 112013058279111-pat00065
Figure 112013058279111-pat00065

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 9-(3-bromophenyl)-9H-carbazole(7.4g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 81을 11.6g(수율 75%) 수득하였다.9- (3-bromophenyl) -9H-carbazole (7.4 g, 0.023 mol / sigma) was added to 4- (4,6-diphenyl-1,3,5-triazin-2-yl) phenylboronic acid (10.0 g, 0.028 mol) 400 ml of THF was added to Pd (PPh3) 4 (1.3g, 0.0011mol) and potassium carbonate (9.5g, 0.069mol), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 11.6 g (yield 75%) of Compound 81.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.52/D, 7.51/M, 7.46/D, 8.09/S, 7.63/D, 7.50/M, 7.29/M, 8.12/D, 8.55/D, 7.25/M, 7.33/M, 7.94/D) 2H(7.41/M, 7.25/D, 7.85/D) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.52 / D, 7.51 / M, 7.46 / D, 8.09 / S, 7.63 / D, 7.50 / M, 7.29 / M, 8.12 / D, 8.55 / D (7.28 / D, 7.85 / D) 4H (8.28 / D, 7.51 / M)

LC/MS: m/z= 551[(M+1)+]LC / MS: m / z = 551 [(M + 1) < + &

실시예Example 17: 화합물 82 합성 17: Compound 82 Synthesis

Figure 112013058279111-pat00066
Figure 112013058279111-pat00066

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 2-(4-bromophenyl)-1-phenyl-1H-benzo[d]imidazole(8.0g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol/sigma Aldrich)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 82를 11.6g(수율 71%) 수득하였다.To a solution of 2- (4-bromophenyl) -l-phenyl-lH-benzo [d] imidazole (10.0 g, 0.028 mol) was added to 4- (4,6-diphenyl-1,3,5-triazin- 400 ml of THF was added to potassium carbonate (9.5 g, 0.069 mol / sigma Aldrich), Pd (PPh3) 4 (1.3 g, 0.0011 mol) . After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and column-purified (n-hexane: MC) to obtain 11.6 g (yield: 71%) of Compound 82.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.59/D, 8.56/D, 7.45/M) 2H(7.41/M, 7.50/D, 7.58/M, 7.22/M) 4H(8.28/D, 7.51/M, 7.25/D, 7.85/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.59 / D, 8.56 / D, 7.45 / M) 2H (7.41 / M, 7.50 / D, 7.58 / M, 7.22 / M) 4H (8.28 / D , 7.51 / M, 7.25 / D, 7.85 / D)

LC/MS: m/z= 578[(M+1)+]LC / MS: m / z = 578 [(M + 1) < + &

실시예Example 18: 화합물 85 합성 18: Compound 85 Synthesis

Figure 112013058279111-pat00067
Figure 112013058279111-pat00067

3-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 2-(4-bromophenyl)-1-phenyl-1H-benzo[d]imidazole(8.0g, 0.023mol), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 85를 12.1g(수율 75%) 수득하였다.To a solution of 2- (4-bromophenyl) -l-phenyl-lH-benzo [d] imidazole (10.0 g, 0.028 mol) was added to 3- (4,6-diphenyl-1,3,5-triazin- (1.3 g, 0.0011 mol), potassium carbonate (9.5 g, 0.069 mol), Pd (PPh3) 4 (400 g), and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 12.1 g (yield 75%) of Compound 85.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.45/M, 8.56/D, 7.59/D, 7.48/D, 7.57/M, 8.24/D, 7.70/S) 2H(7.41/M, 7.25/D, 7.85/D, 7.50/D, 7.58/M, 7.22/M) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.45 / M, 8.56 / D, 7.59 / D, 7.48 / D, 7.57 / M, 8.24 / D, 7.70 / S) 2H (7.41 / M, 7.25 / D, 7.85 / D, 7.50 / D, 7.58 / M, 7.22 /

LC/MS: m/z= 578[(M+1)+]LC / MS: m / z = 578 [(M + 1) < + &

실시예Example 19: 화합물 86 합성 19: Compound 86 Synthesis

Figure 112013058279111-pat00068
Figure 112013058279111-pat00068

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 4-(3-bromophenyl)dibenzo[b,d]thiophene(7.8g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol/), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물 86을 11.6g(수율 73%) 수득하였다.(3-bromophenyl) dibenzo [b, d] thiophene (7.8 g, 0.023 mol) was added to 4- (4,6-diphenyl-1,3,5-triazin- 400 ml of THF was added to Pd (PPh3) 4 (1.3g, 0.0011mol /), potassium carbonate (9.5g, 0.069mol) and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC, and subjected to column purification (n-hexane: MC) to obtain 11.6 g (yield: 73%) of 86.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.57/M, 7.70/S, 8.20/D, 7.58/M, 8.41/D, 8.45/D, 7.52/M, 7.50/M, 7.98/D) 2H(7.41/M, 7.25/D, 7.85/D, 7.48/M) 4H(8.28/D, 7.51/M) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.57 / M, 7.70 / S, 8.20 / D, 7.58 / M, 8.41 / D, 8.45 / D, 7.52 / M, 7.50 / M, 7.98 / D ) 2H (7.41 / M, 7.25 / D, 7.85 / D, 7.48 /

LC/MS: m/z= 568 [(M+1)+]LC / MS: m / z = 568 [(M + 1) < + &

실시예Example 20: 화합물 84 합성 20: Compound 84 Synthesis

(1) (One) 제조예Manufacturing example 20-1: 중간체 84-1 합성 20-1: Synthesis of Intermediate 84-1

Figure 112013058279111-pat00069
Figure 112013058279111-pat00069

4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenylboronic acid(10.0g, 0.028mol)에 3-bromophenylboronic acid(4.6g, 0.023mol/sigma Aldrich), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 중간체 84-1을 9.3g(수율 78%) 수득하였다.3-bromophenylboronic acid (4.6g, 0.023mol / Sigma Aldrich), Pd (PPh3), and the like were added to 4- (4,6-diphenyl-1,3,5-triazin- 4 (1.3 g, 0.0011 mol) and potassium carbonate (9.5 g, 0.069 mol) were added 400 ml of THF and the mixture was reacted at 65 ° C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 9.3 g (yield 78%) of Intermediate 84-1.

LC/MS: m/z= 430 [(M+1)+]LC / MS: m / z = 430 [(M + 1) < + &

(2) (2) 제조예Manufacturing example 20-2: 화합물 84 합성 20-2: Compound 84 Synthesis

Figure 112013058279111-pat00070
Figure 112013058279111-pat00070

중간체 84-1(10.0g, 0.023mol)에 2-bromo-9,9-diphenyl-9H-fluorene(7.6g, 0.019mol), Pd(PPh3)4(1.3g, 0.0011mol), potassium carbonate(9.5g, 0.069mol)에 THF 400ml를 넣고 65℃에서 18시간 교반하여 반응시켰다. 반응 종료 후 냉각하여 H20 : MC에 층분리 후 컬럼정제(n-Hexane :MC)하여 화합물84를 9.6g(수율 72%) 수득하였다.Pd (PPh3) 4 (1.3 g, 0.0011 mol), potassium carbonate (9.5 g, 0.011 mol), and 2-bromo-9,9-diphenyl-9H- g, 0.069 mol), and the mixture was reacted at 65 DEG C for 18 hours with stirring. After completion of the reaction, the reaction mixture was cooled, separated into H 2 O: MC and subjected to column purification (n-hexane: MC) to obtain 9.6 g (yield: 72%) of Compound 84.

H-NMR (200MHz, CDCl3):δ ppm, 1H(7.26/M, 7.70/S, 7.57/M, 7.77/D, 7.63/D, 7.93/D, 7.87/D, 7.38/M, 7.28/M, 7.55/D, 7.26/M) 2H(7.41/M, 7.85/D, 7.25/D, 7.48/D) 4H(8.28/D, 7.51/M, 7.33/M, 7.11/D) H-NMR (200MHz, CDCl 3 ): δ ppm, 1H (7.26 / M, 7.70 / S, 7.57 / M, 7.77 / D, 7.63 / D, 7.93 / D, 7.87 / D, 7.38 / M, 7.28 / M (7.58 / D, 7.26 / M) 2H (7.41 / M, 7.85 / D, 7.25 / D, 7.48 / D)

LC/MS: m/z= 702 [(M+1)+]
LC / MS: m / z = 702 [(M + 1) < + &

본 발명의 실시예에서 쓰이는 약어는 아래와 같다.Abbreviations used in the embodiment of the present invention are as follows.

NPB: N,N'-Bis(naphthalen-1-yl)-N,N'-bis(phenyl)benzidineNPB: N, N'-bis (naphthalen-1-yl) -N,

Ir(ppy)3: Iridium, tris(2-phenylpyidine)Ir (ppy) 3 : Iridium, tris (2-phenylpyidine)

Balq: Bis(2-methyl-8-quinolinolato-N1,O8)-(1,1'-Biphenyl-4-olato)aluminumBalq: Bis (2-methyl-8-quinolinolato-N1, O8) - (1,1'-Biphenyl-4-olato) aluminum

Alq3: tris(8-quinolinolato)-aluminium(III)Alq 3 : tris (8-quinolinolato) -aluminium (III)

CBP: (4,4-N,N-dicarbazole)biphenyl
CBP: (4,4-N, N-dicarbazole) biphenyl

소자실시예Device Example 1: 화합물 1을  1: Compound 1 발광층의The light- 호스트 재료로 하여  As a host material 유기전계발광소자Organic electroluminescent device 제조 Produce

ITO로 코팅된 유리기판 위에 NPB를 증착하여 120nm의 정공수송층을 형성하였으며, 이어서 Ir(ppy)3을 도펀트로 하여 화합물 1의 증착속도를 0.1nm/sec, Ir(ppy)3 증착속도를 0.009nm/sec로 증착하고, 증착속도 비율이 9%가 되도록 Ir(ppy)3을 도핑하여 정공수송층 상에 발광층을 30nm 두께로 형성하였다.Depositing NPB on the glass substrate coated with ITO to form a hole transport layer was of 120nm, followed by Ir (ppy) the deposition rate of the compounds 1 to 3 as the dopant 0.1nm / sec, Ir (ppy) 3 deposition rate 0.009nm / sec, and Ir (ppy) 3 was doped so that the deposition rate ratio was 9% to form a light emitting layer with a thickness of 30 nm on the hole transport layer.

그 위에 Balq를 10nm 두께로 증착하여 정공이 발광층을 지나 전자수송층으로 이동하는 것을 방지하는 정공차단층을 형성하고, 그 위에 Alq3을 증착하여 40nm의 전자수송층을 형성하였으며, 그 위에 불화리튬을 증착하여 1nm의 전자주입층을 형성하였다. 전자주입층 상에 알루미늄을 증착하여 120nm의 음극을 형성하여 유기전계발광소자를 제조하였다.Balq was deposited thereon to a thickness of 10 nm to form a hole blocking layer for preventing holes from moving to the electron transporting layer through the light emitting layer, and Alq 3 was deposited thereon to form an electron transporting layer having a thickness of 40 nm. Lithium fluoride Thereby forming an electron injection layer having a thickness of 1 nm. Aluminum was deposited on the electron injecting layer to form a 120 nm cathode, thereby fabricating an organic electroluminescent device.

이때, 각 물질의 증착속도는 유기물질인, 화합물 1, NPB, Alq3, Balq는 0.1 nm/sec, 불화리튬은 0.01 nm/sec, 알루미늄은 0.5 nm/sec로 하였다.At this time, the deposition rate of each material was set to 0.1 nm / sec for compound 1, NPB, Alq 3 , Balq, 0.01 nm / sec for lithium fluoride, and 0.5 nm / sec for aluminum.

소자실시예Device Example 2 내지 20 2 to 20

소자실시예 2 내지 20은 화합물 1 대신에 하기 표 1에 기재된 화합물을 발광재료로 사용한 것을 제외하고는 소자실시예 1과 동일한 방법으로 유기전계발광소자를 제조하였다.Device Examples 2 to 20 An organic electroluminescent device was manufactured in the same manner as in Example 1 except that the compound described in Table 1 was used instead of Compound 1 as a light emitting material.

소자비교예Device comparison example 1 One

상기 화합물 1 대신 (4,4-N,N-dicarbazole)biphenyl(CBP)를 발광재료로 사용한 것을 제외하고는 소자실시예 1과 동일한 방법으로 소자비교예 1의 유기전계발광소자를 제조하였다.
An organic electroluminescent device of Comparative Example 1 was prepared in the same manner as in Example 1 except that (4,4-N, N-dicarbazole) biphenyl (CBP)

이하, 상기 소자실시예 1 내지 20과 소자비교예 1에 따라 제조된 유기전계발광소자의 특성을 비교한 결과를 하기 표 1 에 나타내었다.Hereinafter, the characteristics of the organic electroluminescent device manufactured according to the device embodiments 1 to 20 and the device comparison example 1 are compared and the results are shown in Table 1 below.

발광재료Emitting material 구동전압(V)
(at 1000cd/m2)
The driving voltage (V)
(at 1000 cd / m 2 )
발광효율
(cd/A)
Luminous efficiency
(cd / A)
색좌표
(CIE(x,y))
Color coordinates
(CIE (x, y))
소자실시예1Device Embodiment 1 화합물1Compound 1 6.16.1 2323 (0.33,0.63)(0.33, 0.63) 소자실시예2Device Example 2 화합물5Compound 5 6.06.0 2222 (0.33,0.63)(0.33, 0.63) 소자실시예3Device Embodiment 3 화합물6Compound 6 6.26.2 2222 (0.33,0.63)(0.33, 0.63) 소자실시예4Device Example 4 화합물14Compound 14 5.85.8 2424 (0.33,0.63)(0.33, 0.63) 소자실시예5Element Embodiment 5 화합물2Compound 2 5.55.5 2121 (0.33,0.63)(0.33, 0.63) 소자실시예6Device Example 6 화합물16Compound 16 5.85.8 2626 (0.33,0.64)(0.33, 0.64) 소자실시예7Device Example 7 화합물17Compound 17 5.95.9 2525 (0.33,0.63)(0.33, 0.63) 소자실시예8Device Example 8 화합물18Compound 18 5.75.7 2525 (0.33,0.63)(0.33, 0.63) 소자실시예9Device Example 9 화합물19Compound 19 6.06.0 2323 (0.33,0.64)(0.33, 0.64) 소자실시예10Element Embodiment 10 화합물47Compound 47 6.06.0 2323 (0.33,0.63)(0.33, 0.63) 소자실시예11Element Embodiment 11 화합물76Compound 76 5.95.9 2222 (0.32,0.63)(0.32, 0.63) 소자실시예12Device Example 12 화합물77Compound 77 5.85.8 2323 (0.33,0.63)(0.33, 0.63) 소자실시예13Device Embodiment 13 화합물78Compound 78 6.16.1 2424 (0.33,0.63)(0.33, 0.63) 소자실시예14Device Embodiment 14 화합물79Compound 79 6.16.1 2222 (0.33,0.63)(0.33, 0.63) 소자실시예15Device Example 15 화합물80Compound 80 5.75.7 2121 (0.32,0.63)(0.32, 0.63) 소자실시예16Device Embodiment 16 화합물81Compound 81 5.85.8 2222 (0.33,0.63)(0.33, 0.63) 소자실시예17Device Example 17 화합물82Compound 82 5.85.8 2323 (0.33,0.63)(0.33, 0.63) 소자실시예18Element Embodiment 18 화합물85Compound 85 5.95.9 2222 (0.33,0.63)(0.33, 0.63) 소자실시예19Element Embodiment 19 화합물86Compound 86 5.75.7 2525 (0.32,0.63)(0.32, 0.63) 소자실시예20Device Embodiment 20 화합물84Compound 84 6.06.0 2222 (0.33,0.64)(0.33, 0.64) 소자비교예1Device Comparative Example 1 CBPCBP 6.56.5 1919 (0.33,0.63)(0.33, 0.63)

구동전압 및 발광효율 측정Measurement of driving voltage and luminous efficiency

위에서 만든 유기발광소자(기판크기: 25*25mm2/증착면적: 2*2mm2)를 IVL 측정셋트(CS-2000+지그+IVL프로그램)에 고정 한 후 전류를 1mA/m2씩 상승시키며 증착면의 발광 휘도(cd/m2), 구동전압(V), 전류밀도(A/m2), 발광효율(cd/A)을 측정하여 휘도가 1000cd/m2 일 때 구동전압과 발광효율을 상기 표 1에 나타내었다.The organic light emitting element made from above (substrate size: 25 * 25mm 2 / deposition area: 2 * 2mm 2) an IVL measuring set (CS-2000 + fixture + IVL program) by the current deposition raises by 1mA / m 2 and then fixed to the the brightness of light emitted by the surface (cd / m 2), a driving voltage (V), current density (a / m 2), luminous efficiency (cd / a) drive voltage when measured brightness is 1000cd / m 2 days and luminous efficiency Shown in Table 1 above.

표 1에 따르면, 본 발명에 따른 유기전계발광소자용 화합물이 유기전계발광소자의 발광층의 호스트 물질로 사용될 때 종래의 CBP를 발광재료로 사용할 때보다 구동전압은 상당히 떨어지고, 발광효율은 상당히 향상된 것을 알 수 있다.According to Table 1, when the compound for an organic electroluminescence device according to the present invention is used as a host material of a light emitting layer of an organic electroluminescence device, the driving voltage is considerably lower than that of the conventional CBP as a light emitting material and the luminous efficiency is considerably improved Able to know.

Claims (12)

하기 [구조식 1]로 표시되는 유기전계발광소자용 화합물.
[구조식 1]
Figure 112015048358165-pat00117

상기 [구조식 1]에서,
X1 내지 X8은 서로 같거나 다를 수 있고, X1 내지 X8은 각각 독립적으로 질소원자 또는
Figure 112015048358165-pat00118
이고,
R1 내지 R4는 서로 같거나 다를 수 있고, R1 내지 R4는 각각 독립적으로 수소원자, C1 내지 C30 알킬기, C6 내지 C30 아릴기, 또는 C1 내지 C30 헤테로아릴기이며,
R5는 수소원자이고,
B는
Figure 112015048358165-pat00119
또는
Figure 112015048358165-pat00120
이고, A는 수소원자이다.
A compound for an organic electroluminescence device represented by the following structural formula (1).
[Structural formula 1]
Figure 112015048358165-pat00117

In the above formula 1,
X 1 to X 8 may be the same or different from each other, X 1 to X 8 each independently represents a nitrogen atom or
Figure 112015048358165-pat00118
ego,
R 1 to R 4 may be the same or different from each other and each of R 1 to R 4 independently represents a hydrogen atom, a C1 to C30 alkyl group, a C6 to C30 aryl group, or a C1 to C30 heteroaryl group,
R 5 is a hydrogen atom,
B is
Figure 112015048358165-pat00119
or
Figure 112015048358165-pat00120
And A is a hydrogen atom.
삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 제1전극, 제2전극 및 상기 제1전극과 제2전극 사이에 단수 또는 복수의 유기물층을 포함하는 유기전계발광소자에 있어서,
상기 단수 또는 복수의 유기물층은 발광층, 전자주입층, 전자수송층, 정공차단층, 전자차단층, 정공수송층 및 정공주입층 중에서 선택된 1종 이상을 포함하고,
상기 발광층은 호스트와 도펀트를 포함하고, 상기 호스트가 제1항에 따른 유기전계발광소자용 화합물인 것을 특징으로 하는 유기전계발광소자.
1. An organic electroluminescent device comprising a first electrode, a second electrode, and a single or a plurality of organic layers between the first electrode and the second electrode,
The single or plural organic material layers include at least one selected from a light emitting layer, an electron injecting layer, an electron transporting layer, a hole blocking layer, an electron blocking layer, a hole transporting layer and a hole injecting layer,
Wherein the light emitting layer comprises a host and a dopant, and the host is the compound for an organic electroluminescence device according to any one of claims 1 to 6. [
삭제delete 삭제delete 삭제delete
KR1020130075402A 2013-06-28 2013-06-28 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same KR101593465B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130075402A KR101593465B1 (en) 2013-06-28 2013-06-28 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130075402A KR101593465B1 (en) 2013-06-28 2013-06-28 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Publications (2)

Publication Number Publication Date
KR20150002072A KR20150002072A (en) 2015-01-07
KR101593465B1 true KR101593465B1 (en) 2016-02-12

Family

ID=52475584

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130075402A KR101593465B1 (en) 2013-06-28 2013-06-28 Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Country Status (1)

Country Link
KR (1) KR101593465B1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11084806B2 (en) 2016-07-12 2021-08-10 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device
US11158817B2 (en) 2017-01-05 2021-10-26 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device
US11264574B2 (en) 2016-07-29 2022-03-01 Samsung Sdi Co., Ltd. Composition for organic optoelectronic element, organic optoelectronic element, and display device
US11678572B2 (en) 2016-06-29 2023-06-13 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus
US11706975B2 (en) 2016-06-29 2023-07-18 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102473857A (en) 2010-01-15 2012-05-23 出光兴产株式会社 Organic electroluminescent element
KR101882592B1 (en) 2013-11-13 2018-08-24 이데미쓰 고산 가부시키가이샤 Compound, material for organic electroluminescent element, organic electroluminescent element, and electronic device
KR20150115622A (en) 2014-04-04 2015-10-14 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
CN109912523B (en) * 2014-04-04 2023-07-11 株式会社Lg化学 Heterocyclic compound and organic light-emitting device comprising same
KR101542714B1 (en) 2014-04-04 2015-08-12 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
KR101537500B1 (en) 2014-04-04 2015-07-20 주식회사 엘지화학 Organic light emitting diode
US20170222159A1 (en) * 2014-07-29 2017-08-03 Rohm And Haas Electronic Materials Korea Ltd. Electron buffering material and organic electroluminescent device
KR101864473B1 (en) * 2014-09-22 2018-06-04 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
KR102611317B1 (en) 2014-12-24 2023-12-07 솔루스첨단소재 주식회사 Organic compound and organic electro luminescence device comprising the same
KR102360221B1 (en) * 2015-01-08 2022-02-09 솔루스첨단소재 주식회사 Organic electro luminescence device
JP6580613B2 (en) * 2016-02-15 2019-09-25 国立大学法人山形大学 Lighting for plant cultivation using a novel triazine compound
KR20170109430A (en) * 2016-03-21 2017-09-29 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same
KR102385482B1 (en) * 2016-04-29 2022-04-12 메르크 파텐트 게엠베하 Materials for organic electroluminescent devices
WO2017221999A1 (en) 2016-06-22 2017-12-28 Idemitsu Kosan Co., Ltd. Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes
KR20180035554A (en) * 2016-09-29 2018-04-06 롬엔드하스전자재료코리아유한회사 Organic electroluminescent device comprising electron transport layer and electron buffer layer
KR102628129B1 (en) * 2016-12-27 2024-01-23 닛테츠 케미컬 앤드 머티리얼 가부시키가이샤 Material for organic electroluminescent element, and organic electroluminescent element
JPWO2018139662A1 (en) * 2017-01-30 2019-12-26 出光興産株式会社 Organic electroluminescence device and electronic equipment
WO2020027506A1 (en) * 2018-07-30 2020-02-06 Rohm And Haas Electronic Materials Korea Ltd. A plurality of host materials and organic electroluminescent device comprising the same
WO2020035365A1 (en) * 2018-08-13 2020-02-20 Cynora Gmbh Organic molecules for optoelectronic devices
WO2021132733A1 (en) * 2019-12-23 2021-07-01 Idemitsu Kosan Co., Ltd. Polycyclic compound, material for an organic electroluminescence device and an organic electroluminescence device comprising the polycyclic compound
WO2021230141A1 (en) * 2020-05-12 2021-11-18 出光興産株式会社 Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic device
CN112321585B (en) * 2020-10-30 2022-04-22 华南理工大学 Asymmetric substituted diphenyl pyridine compound and preparation and application thereof
CN116199671A (en) * 2021-11-29 2023-06-02 广州华睿光电材料有限公司 Organic compound, mixture, composition and organic electronic device comprising same
CN117480163A (en) * 2021-12-16 2024-01-30 株式会社Lg化学 Compound and organic light emitting device comprising the same
KR20230114063A (en) * 2022-01-24 2023-08-01 주식회사 엘지화학 Novel compound and organic light emitting device comprising the same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009021336A (en) * 2007-07-11 2009-01-29 Konica Minolta Holdings Inc Organic electroluminescent element, display device, and lighting device
WO2012087960A1 (en) * 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Triazine derivatives for electronic applications

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013783A1 (en) * 2009-07-31 2011-02-03 富士フイルム株式会社 Organic electroluminescent element

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009021336A (en) * 2007-07-11 2009-01-29 Konica Minolta Holdings Inc Organic electroluminescent element, display device, and lighting device
WO2012087960A1 (en) * 2010-12-20 2012-06-28 E. I. Du Pont De Nemours And Company Triazine derivatives for electronic applications

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11678572B2 (en) 2016-06-29 2023-06-13 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus
US11706975B2 (en) 2016-06-29 2023-07-18 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device and display apparatus
US11084806B2 (en) 2016-07-12 2021-08-10 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device, organic optoelectronic device, and display device
US11264574B2 (en) 2016-07-29 2022-03-01 Samsung Sdi Co., Ltd. Composition for organic optoelectronic element, organic optoelectronic element, and display device
US11158817B2 (en) 2017-01-05 2021-10-26 Samsung Sdi Co., Ltd. Compound for organic optoelectronic device, composition for organic optoelectronic device and organic optoelectronic device and display device

Also Published As

Publication number Publication date
KR20150002072A (en) 2015-01-07

Similar Documents

Publication Publication Date Title
KR101593465B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101521790B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101447961B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101550429B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101447959B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101527181B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101584753B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101626523B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101499102B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101401639B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101468493B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150107442A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150012974A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150022615A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20140004549A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150059680A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20130069431A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101396552B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20160041223A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101562883B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150106067A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101576921B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR20150037133A (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101562882B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same
KR101516279B1 (en) Novel compound for organic electroluminescent device and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee